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Abstract:	  Cystic fibrosis (CF) is one of the most common autosomal recessive genetic disorders, 
resulting in faulty chloride ion channels in the lungs. As a result, the lungs are severely 
compromised with viscous secretions leading to chronic and repeated infections, and the 
colonization of a diverse microbial community. Pseudomonas aeruginosa is one of the primary 
pathogens in the CF lung and prior research has demonstrated a high degree of phenotypic 
heterogeneity among adult isolates in comparison to control strains. This study has two aims: 
First, the creation of an open repository of sputum and isolates collected from the Oklahoma 
Cystic Fibrosis clinic in Oklahoma City, OK to serve as a resource for research groups to use in 
polymicrobial studies. Second, the assay for a number of virulence factors using a subset of P. 
aeruginosa CF isolates recovered from two patients in each age category: children (under 13), 
adolescents (13-18), and adults (over 18). The collected repository includes sputum samples from 
57 patients demonstrating a wide range of recoverable growth and a broad diversity of observed 
colony morphologies on nutrient and selective media. Thirty isolates per patient were assayed for 
surface motility (swim, swarm, and twitch) and production of hydrogen cyanide, biosurfactant, 
casein proteases, elastases, siderophores, and fluorescent pigments. P. aeruginosa isolates from 
most patients showed a high degree of consistency in producing hydrogen cyanide, fluorescent 
pigments, casein proteases, elastases, siderophores, and biosurfactant.  There was, however, 
variability seen in the different surface motilities of isolates between the different age groups.  
These results provide insights to the variability of P. aeruginosa between age groups and confirm 
differences between P. aeruginosa isolated from newly infected CF patients and those chronically 
infected for many years. Further characterization and deeper understanding of the polymicrobial 
community in the CF lung are required to improve clinical diagnosis and treatment. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
 
Cystic fibrosis (CF) is an autosomal disorder affecting approximately 30,000 individuals 
in the United States [22]. It results from mutations in the cystic fibrosis transmembrane regulator 
(CFTR) gene [22]. Although CF was first observed in infants with pancreatic problems, it is 
widely studied for its contributions to pulmonary decline [22]. The most notable feature of 
pulmonary CF is the production of viscous mucus in the lungs allowing for the retention of a rich 
polymicrobial community that would otherwise be expelled [85]. 
The polymicrobial community in the CF lung has presented a new direction for CF 
research. In childhood, the dominant pathogens are Staphylococcus aureus and Haemophilus 
influenzae. As a patient ages and becomes infected with Pseudomonas aeruginosa, the lung 
maintains the same microbial load but P. aeruginosa dominates the lung. The degree of 
cooperativity between P. aeruginosa and other CF pathogens such as Burkholderia cepacia 
complex is thought to enhance the virulence of the dominant pathogen [12], and places emphasis 
on the need to understand interspecies interactions in detail.
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Due to its genetic flexibility, P. aeruginosa clones demonstrate a high degree of 
phenotypic variance even within the same patient [107]. Among the phenotypes studied by 
Workentine et al. [107], many are virulence factors contributing to the pathogenicity of P. 
aeruginosa such as protease and siderophore production, and swarm, swim, and twitch motility. 
Most research is focused on adult patients and provides little insight to the early years of infection 
in children and adolescents. Moreover, obtaining sputum from children and adolescents presents 
another challenge for CF research. Parents and guardians of young patients are often 
uncomfortable with external studies and prefer to limit their children’s participation. Because 
children and adolescents do not readily produce sputum as much as adults do, it is easier to 
collect throat swab cultures from them, but this may not be an accurate representation of 
infections in the lower airways. With this being said, a combination of challenges presents a 
serious gap in heterogeneity studies. 
This study has two aims in order to address these gaps. First, the creation of a repository 
of CF sputum and isolates from all ages will address the challenge of obtaining suitable samples 
for research use. By setting up an open access library of samples, this fosters collaborations with 
interested research groups to further enhance our current knowledge and understanding of the CF 
lung and associated infections. Second, surveying P. aeruginosa strains collected from patients at 
the Oklahoma Cystic Fibrosis clinic will address gaps in heterogeneity studies. We hypothesize 
that P. aeruginosa strains recovered from cystic fibrosis sputa from children (under 13), 
adolescents (13-18), and adults (over 18) will exhibit differences in virulence factor production 
between the three age groups. Additionally, heterogeneity is also expected between isoaltes 
obtained from the same patient.  
3	  
	  
CHAPTER II 
 
 
REVIEW OF LITERATURE 
 
 
 
I. Cystic Fibrosis  
Cystic fibrosis (CF) is one of the most common autosomal recessive disorders, affecting 
approximately 30, 000 individuals in the United States (reviewed in [22]). Mutations in the cystic 
fibrosis transmembrane conductance regulator (CFTR) negatively affect the epithelial lining of 
the lungs [22] and allow for the retention of a diverse microbial community that would otherwise 
be expelled [85]. Cystic fibrosis, also referred to as mucoviscidosis, first gained attention as a 
pancreatic ailment resulting in lesions and malnutrition. At the time, the understanding of the 
disease was that it was a collection of related clinical states. However, this dogma changed when 
the work of Dorothy Andersen was published in 1938 [67], which provided a genetic 
understanding of what was previously considered to be a collection of disease states to a single 
disease with many clinical manifestations and effects [3]. Further work led to the establishment of 
a few key observations common to CF individuals. The sweat of CF patients contains abnormally
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high concentrations of sodium (Na+), chloride (Cl-), and potassium (K+) ions [30, 67]. Those 
patients who reach adulthood are also sterile [95].  
While the alimentary effects of CF have been studied, much research focuses on the 
respiratory manifestation of CF, particularly on the repeated bacterial infections of the lungs. 
These infections are typically prevented in a healthy individual through a number of innate host 
defense mechanisms. In CF, mutations in the CFTR gene result in malfunctioning chloride (Cl-) 
ion transporters in epithelial cells, leading to viscous mucus secretions and accounts for the 
increased levels of ions in the sweat. The most common mutation in the CFTR gene is a ΔF508 
frameshift mutation that encodes isoleucine instead of phenylalanine (reviewed in [67]). The 
defective protein is accumulated in the endoplasmic reticulum [39, 67] and does not traffic to the 
Golgi [67, 106], an action necessary for membrane expression. As such, the ΔF508 mutation 
results in low Cl- transport across the epithelial membrane and contribute to abnormal epithelial 
fluid secretions [67].  
The classification of CF as an infectious disease stems from repeated invasion of the 
normally sterile lungs by opportunistic pathogens such as Staphylococcus aureus, Haemophilus 
influenzae, and Pseudomonas aeruginosa [67]. This repeated invasion is partially due to poor 
action of the mucocilliary escalator in the trachea, which normally moves mucus secretions from 
the lungs up to the throat to be expelled or swallowed and destroyed in the stomach [67]. In CF, 
poor Cl- ion transport across the epithelial cell membranes thickens the mucus, creating plugs that 
serve as a breeding ground for pathogens, and the thickened mucus cannot be easily moved by the 
villi of the mucocilliary escalator [67].  
One of the clinical symptoms associated with CF is the intermittent occurrence of 
pulmonary exacerbations. An exacerbation is loosely defined as a period of acute worsening of 
symptoms and is associated with a decrease in lung function [41]. Exacerbations are usually 
5	  
	  
treated with antibiotic therapies to eradicate pathogens that may be causing pulmonary decline 
through host-pathogen responses such as inflammation. 
The relationship between airway inflammation and infection has been the subject of 
several studies. In a normal immune response, inflammation serves to quickly bring neutrophils 
and macrophages to the site of infection to eradicate pathogens (reviewed in [35]). Inflammation 
is normally self-limiting [35], however, in CF, the airways experience chronic inflammation due 
to the recognition of whole pathogens such as respiratory viruses or pathogen-associated 
molecular patterns (PAMPs), which are components shed by pathogens such as flagellum and 
lipopolysaccharide (reviewed in [75]).  PAMPs bind to receptors on the epithelial cells to 
stimulate an inflammatory response [75].  
It has been suggested that exaggerated inflammation in response to early infections with 
pathogens such as S. aureus causes initial tissue damage [67]. However, it has also been 
suggested that lung damage may also occur before chronic pathogenic infections occur in the 
lungs due to the increased number of neutrophils and the elevated amounts of neutrophil elastase, 
α1 –antiprotease, and interlukin-8 (IL-8) present in bronchoalveolar lavage (BAL) fluid taken 
from infants with CF [55]. In this study, seven of the sixteen infants did not culture any CF 
pathogens from the BAL fluid but still had increased numbers of neutrophils and levels of IL-8 
[55]. 
In a comparative study of bronchial epithelial cells from CF and non-CF individuals, 
Bonfield, et al. measured the levels of secreted anti-inflammatory cytokine IL-10, and pro-
inflammatory cytokines IL-8 and IL-6 [11].  Their study revealed that non-CF epithelial cells 
secrete IL-10 but no pro-inflammatory cytokines [11]. On the other hand, CF epithelial cells 
secrete pro-inflammatory cytokines but not IL-10 [11]. This difference between non-CF and CF 
epithelial cell cytokine production may be due to continuous stimuli from pathogens or PAMPs 
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present in the lungs. Furthermore, another study demonstrated that P. aeruginosa stimulates the 
release of pro-inflammatory cytokine IL-8 by bronchial epithelial cells [32]. An elevated level of 
activated NF-κB in epithelial cells also contributes to the continuous inflammatory response [31].  
This failure to regulate pro-inflammatory signaling by epithelial cells has led to the use of 
anti-inflammatory therapies such as ibuprofen to improve patient symptoms [57]. However, the 
link between chronic airway inflammation, microbial infection, and CF is still not well 
understood despite years of research. How do pathogens continue to thrive in the lungs despite 
the constant recruitment of neutrophils by IL-8? One study suggests that the elevated Cl- 
concentration in the CF lung may inhibit neutrophil phagocytosis [100], indicating that the 
abnormal secretions in the CF lung may play a role in pathogen persistence and ineffective killing 
by neutrophils. As such, chronic inflammation in CF is marked by the presence of neutrophils and 
pro-inflammatory cytokines in the sputum [89]. During periods of pulmonary exacerbations, 
inflammation increases in the lungs, but whether this heightened response is due to increased 
epithelial cell recognition of PAMPs remains under debate. 
 
I. a. Major Pathogens of Cystic Fibrosis  
Pseudomonas aeruginosa is one of the primary pathogens in the CF lung and prior 
research has demonstrated a high phenotypic variability among adult isolates in comparison to 
control strains [107]. Other major pathogens include Haemophilus influenzae, Burkholderia 
cepacia complex (BCC) [12] and Staphylococcus aureus [69]. In childhood, the dominant 
pathogens are S. aureus and H. influenzae [67]. As a patient ages and becomes infected with P. 
aeruginosa, the lungs maintain the same microbial load but P. aeruginosa or B. cepacia complex 
dominates the lung, replacing less virulent microorganisms frequently found in the oral cavity 
with more severe pathogens [28]. Infection with B. cepacia complex is often of high concern, as 
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patients may succumb to “cepacia syndrome,” a fatal condition brought about by rapid onset of 
necrotizing pneumonia [40] or septicemia [112]. 
 
I. b. Polymicrobial infections in the CF lung  
It has been well appreciated that CF individuals possess a unique microbiome among 
each other and that their polymicrobial communities are also different from those of non-CF 
individuals [28, 37]. This presents a challenge for therapeutic strategies and places identification 
of the polymicrobial community members a high priority for effective diagnosis and care.Current 
research is focused on understanding the polymicrobial community present in the CF lung. 
Traditional sputum studies were conducted under aerobic conditions and indicated that a select 
group of microorganisms colonized the CF lung in a particular order, beginning with H. 
influenzae and S. aureus and ending with P. aeruginosa and B. cepacia complex dominant 
infections [37, 85]. However, other opportunistic pathogens such as non-tuberculosis 
Mycobacterium, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans have been 
cultured with increased frequency in recent years [37]. 
However, aerobic-based studies are misrepresentative of the true nature of the CF lung 
microbiome. The levels of oxygen present in the lungs fluctuate as mucus accumulates in the 
airways and are cleared by expectoration. Therefore, it is possible that anaerobic microorganisms 
may colonize the lungs as well.  Both facultative and obligate anaerobes have been cultured from 
sputum in addition to the traditional aerobic pathogens [28, 37, 87]. As respiratory viral infections 
are also common in CF patients, other researchers began to address the question of what other 
microorganisms are present in the sputum. When fungi were cultured from sputum, the need for a 
more sensitive and high throughput method of detection became a priority when it became 
apparent the CF community was more complex than previously thought.  
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With the advent of next-generation sequencing, the study of CF microbiome became 
more feasible. Using culture-independent techniques, Delhaes, et al. identified several members 
of the polymicrobial community, including opportunistic fungal pathogens such as Aspergillus 
fumigatis, yeasts such as Candida albicans, anaerobic bacteria, and traditional CF pathogens such 
as P. aeruginosa [28]. In another microbiome study conducted by Fodor, et al. [37], the impact of 
exacerbations and antibiotic treatment on the microbial community was assessed. They showed 
that, at the end of exacerbations Pseudomonas and Burkholderia populations did not significantly 
or consistently decrease when compared to the onset of exacerbation or during clinically stable 
periods [37]. Moreover, antibiotic treatment affected a small number of less abundant 
microorganisms such as Neisseria and Pasteurella, reducing their numbers or clearing them 
entirely from the lungs [37]. However, treatment during exacerbations with high doses of 
antibiotics is usually associated with temporary improvement of clinical status [37], as shown by 
changes in community structure after antibiotic treatment as opposed to during periods of stability 
and the beginning of exacerbation periods [37]. The use of culture-independent techniques for 
rapid identification of all members of the complex and highly diverse community present in the 
lower airways might prove useful in prescribing a personalized and effective drug treatment plan 
[28]. 
Other studies focused on assessing the active rather than the total community in CF 
lungs. This technique ensures that the active members of the community are targeted with 
personalized antibiotics even if they are present in low numbers. Metabolically active community 
is investigated by assessing the levels of the RNA rather than the DNA. Metabolic activity 
measured by Reverse Transcription Terminal Restriction Fragment Length Polymorphism (RT-T-
RFLP) in comparison to Terminal Restriction Fragment Length Polymorphism (T-RFLP) showed 
that microorganisms present in low numbers, such as B. cepacia complex, were metabolically 
active [87]. 
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I. c. Polymicrobial interactions in the CF lung 
Inter- and intra-species interactions play a major role in determining the overall effect 
that the polymicrobial community will have on the clinical status of the host. In particular, the 
interactions between S. aureus, B. cenocepacia, and P. aeruginosa are of particular interest owing 
to their prevalence in the CF lung and their impact on mortality. It has been observed that the CF 
lung contains a lower microbial diversity in comparison to the microbial communities present on 
the skin or in the gut [28]. However, this reduced diversity in fungal and bacterial populations 
was associated with poorer clinical status and decreased lung function [28]. Therefore, the select 
group of pathogens colonizing the CF lung interacts with each other using a variety of signaling 
mechanisms and synergistic interactions. 
An important feature of polymicrobial communities is community surveillance, which is 
defined as the ability of one pathogen to sense and respond to stimuli from another pathogen [58]. 
For example, upon exposure to N-acetylglucosamine (GlcNAc), a component of peptidoglycan, 
P. aeruginosa increases the production of Pseudomonas quinolone signal (PQS)-regulated 
virulence factors [58]. Gram-positive bacteria that shed high amounts of GlcNAc are co-cultured 
with P. aeruginosa, who in turn express higher than wild type amounts of pyocyanin. Further 
work showed that GlcNAc induces pqsA transcription, the first gene in the synthesis of PQS, and 
thereby induces pyocyanin and elastase production [58]. In a Drosophila melanogaster infection 
model, the commensal Gram-positives in the crop served as the primary source for peptidoglycan. 
This suggests that the production of elastase induced by the transcription of pqsA [58] allows for 
the lysis of Gram positives not only to harvest nutrients from the lysed cell, but also to reduce 
competition [7]. The increased production of PQS-mediated toxins is an effect of community 
surveillance and not the result of mutational overproduction of pyocyanin and elastase.  
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Interactions between P. aeruginosa and the dimorphic yeast Candida albicans are 
dependent on secreted signals from both species. N-acyl-homoserine lactone (AHL) quorum-
sensing signals from P. aeruginosa are able to influence C. albicans morphology, allowing it to 
switch from yeast to filamentous morphologies depending on the amount of AHL signals present 
in co-cultures [70]. Farnesol, a secreted C. albicans virulence factor that represses the switch 
from yeast to filamentous morphologies, is capable of reducing swarming motility in P. 
aeruginosa [70]. These results imply that bacterial-fungal interactions may play a greater role in 
the polymicrobial community of the CF lung and contribute to the persistence of chronic 
polymicrobial infections.  
A long established tenant of CF chronic infections is the necessity for biofilm formation. 
Biofilms in the lung contribute to antimicrobial resistance and poor clearance despite chemical 
therapy. Co-infections of P. aeruginosa and B. cenocepacia in a planktonic culture demonstrate 
that while P. aeruginosa inhibits B. cenocepacia growth, biofilm formation is positively affected 
by B. cenocepacia [12]. When grown alone, P. aeruginosa forms flat biofilms but in mixed 
cultures, it forms filamentous biofilms[12]. Biomass also increases in co-culture [12].  
Perhaps the most curious aspect of the CF lung is the obvious dominance by P. 
aeruginosa in the lung over the presence of other microorganisms. Bragonzi et al. show that co-
infections of P. aeruginosa and B. cenocepacia increase host inflammation response [12].  In 
synergistic biofilms, virulence factor production also increases [12]. In a study conducted by 
Sibley, et. al, polymicrobial infections and community interactions were studied in Drosophila 
melanogaster, an infection model that is often used to study CF infections. Oral microbes, which 
are either avirulent or beneficial to the fly, demonstrate synergy and enhancement of 
pathogenicity of the crop polymicrobial community [96]. Two oral strains, which are 
phenotypically identical in a natural-route Drosophila infection model, are viewed as two 
separate and different infections by the co-infecting P. aeruginosa and by the host’s innate 
11	  
	  
immune system [96]. This result suggests a level of complexity to polymicrobial infections and 
forms the basic framework for further studies in bacterial interactions. 
 
II. Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a Gram-negative rod ubiquitous in soil and water 
environments. It is an opportunistic pathogen of nosocomial concern and is frequently found to 
colonize burn wounds [66]. In the past thirty years, P. aeruginosa has gained attention as a 
bacterium capable of bioremediation and oil recovery due to its production of surface-active 
chemical compounds called biosurfactants [44, 111]. P. aeruginosa is highly motile by both 
flagellum [94] and Type IV pili [14]. It is considered an obligate aerobe, although some strains 
demonstrate growth in facultative anaerobic conditions using nitrate or nitrite as an alternate 
electron acceptor [19].  
The production of a wide variety of virulence factors produced by the bacterium marks it 
as a pathogen of nosocomial concern. It is capable of forming biofilms and an intricate hierarchy 
of quorum sensing systems controls many of its cellular processes. P. aeruginosa is known to 
produce colored pigments which act as signaling molecules, redox cascade inhibitors, and 
siderophores [61, 84]. It also produces a large number of proteases that contribute to tissue 
destruction and evasion of host immune response. Anti-pseudomonal drugs such as ciprofloxacin 
are often prescribed to treat infection but with limited success, as it is highly antimicrobial 
resistant due to the formation of biofilms and the acquisition of antimicrobial resistance plasmids.  
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II. a. Quorum Sensing Systems 
Perhaps the most unique quality of P. aeruginosa is its ability to easily adapt to a wide 
range of environments. This is accomplished through fine-tuning of its phenotypic expression 
using quorum sensing. This adaptive ability is often termed “genetic plasticity” by some 
researchers but this term is misleading since the genome remains relatively constant from isolate 
to isolate. 
P. aeruginosa has three known quorum sensing systems that contribute to the production 
of many virulence factors and interspecies interactions. The first two quorum sensing systems are 
categorized as N-acyl homoserine lactone (AHL) signal systems. These AHLs bind to LuxR-type 
intracellular protein receptors. A related quorum sensing system was first identified in Vibrio 
species. The first of these AHL systems is the las system, a complete quorum sensing system that 
uses 3-oxo-dodecanoyl-homoserine lactone (3-oxo-C12-HSL) as an autoinducer. 3-oxo-C12-HSL 
binds to LasR, a cognate transcriptional regulator. The binding complex controls the expression 
of over 300 genes. Furthermore, the las system controls the activation of the rhl system, but this 
is dependent on nutrient availability [45]. The second AHL system is the rhl system. Its 
autoinducer is N-butanoyl L-homoserine lactone (C4-HSL), which binds to RhlI, which is also a 
cognate transcriptional regulator. The binding complex also controls the expression of 300 genes 
[45]. 
The third quorum sensing system is the Pseudomonas quinolone signal (PQS), which acts 
as one of the primary quorum sensing signals in P. aeruginosa. The autoinducer, 2-heptyl-3-
hydroxy-4-quinolone, binds to the cognate receptor, PqsR, to regulate the production of PQS, 
elastase, rhamnolipids, and pyocyanin [38]. The pqsABCDE operon produces two products, 2-
alkyl-4-quinolones (AQs) and 2-heptyl-4-quinolone (HHQ) [29]. AQs have been detected in the 
supernatant with PQS [29]. AQs also play a role in cell-to-cell communication with other 
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bacteria, a function essential in the CF lung where a diverse microbial community exists. PqsH, a 
monooxygenase whose gene is not part of the pqsABCDE operon, aerobically converts HHQ to 
PQS [38]. Furthermore, HHQ binds to PqsR and induces pqsA transcription [108]. Research 
suggests that the binding of HHQ, despite its lower binding affinity to PqsR in comparison to 
PQS, is important in anaerobic conditions [92]. However, the significance of this accumulation of 
HHQ in anaerobic environments has yet to be studied.  
AQs have been also shown to be vital for interspecies interactions. While PQS is only 
produced by P. aeruginosa, HHQ is produced by P. putida and Burkholderia species produce 
methylated AQs [105]. A study shows that a pqsA mutant of P. aeruginosa is unable to lyse S. 
aureus, suggesting that S. aureus lysis involves AQs or genes regulated by AQs [68]. 
Heptylquinoline-N-oxidase (HQNO) is an AQ that inhibits respiration and the uptake of 
aminoglycosides. The production of HQNO by P. aeruginosa confers protection for S. aureus and 
results in the selection of small colony variant S. aureus [50, 101].  
 
II.b. Denitrification 
Denitrification is described as anaerobic respiration using nitrate (NO3- ) or nitrite (NO2- ) 
as a terminal electron acceptor instead of oxygen. NO3- or NO2- is reduced to gaseous N-oxides 
and N2 in this process [102]. Chen et al. [19] demonstrated that P. aeruginosa is capable of 
denitrification, an ability advantageous in the low oxygen environment of the CF lung and for 
bacterium deep within a biofilm in contrast to those at the surface. The regulation of 
denitrification is controlled by levels of N-oxides and oxygen. These two factors also mediate the 
switch between aerobic respiration and denitrification through the CRP/FNR protein family 
[102].  
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In addition to regulation by environmental levels of N-oxides and oxygen, denitrification 
is also regulated by the quorum sensing molecules of P. aeruginosa [102]. Studies conducted by 
Toyofuku et al. [102] show that the AHL quorum sensing systems, las and rhl, repress 
denitrification. The third quorum sensing system, PQS, affects denitrification by acting on the 
enzyme activity of NO3- reductase (NAR), NO2- (NIR), NO reductase (NOR), and N2O reductase 
(NOS) through iron chelation. Hoffmann, et al. [51] proposed that nutrient availability induced a 
metabolic shift in P. aeruginosa, creating mutant lasR genes. This shift confers resistance to 
multiple antibiotics and a heavy reliance on denitrification to gain energy along with some 
aerobic respiration [51]. 
 
II.c. Biosurfactant  
P. aeruginosa biosynthesizes biosurfactant molecules called rhamonolipids [44]. A 
rhamnolipid is a glycolipid and has the general structure of a hydrophobic fatty acid bound to a 
hydrophilic portion that contains either one or two rhamnose sugars [97] . Research performed by 
Davey et al. [27] indicates that rhamnolipids are required to maintain biofilm architecture by 
opening channels between macrocolonies to allow for the distribution of oxygen and nutrients 
throughout the biofilm.  
 
II.d. Motility 
Motility is often considered to be a virulence factor for its role in host colonization and 
biofilm formation. Three types of motility are studied in depth in this work. The first is 
swimming, and is defined by Henrichson as a kind of surface translocation produced through 
flagellar action [48]. Swimming only occurs on a sufficiently thick surface and the cells move 
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individually and at random in unorganized patterns [48]. In P. aeruginosa, swimming is utilized 
to obtain nutrition, escape toxic substances, and colonize new hosts and environments. Previous 
studies show that mutations in any of the genes involved in flagellum synthesis causes reduced 
virulence [94].  
The second type of motility observed in this study is twitching motility. It is also a type 
of surface translocation but is made possible by Type IVa pilli, a type of adhesin (reviewed in 
[14]). Movement appears intermittent and jerky [48] and is observed in both flagellated and 
unflagellated bacteria. The Type IVa pilli, as an adhesin, promotes surface attachment and is 
important in establishing biofilms (reviewed in [14]). Twitching motility also contributes to 
biofilm architecture development. Mutants are unable to form structurally stable biofilms. With 
regards to pathogenicity, Type Iva pilli are used in the early or acute stages of P. aeruginosa 
infection but are lost in chronic infections either through mutations or down-regulation. 
The third type of motility is swarming. In particular, the swarming motility requires two 
exoproducts to stimulate swarming—rhamnolipids and 3-(3-hydroxyalkanoyloxy) alkanoic acids 
which act as wetting agents and chemotactic stimuli [103]. As previously mentioned, 
rhamnolipids are an integral part in biofilm maintenance and architecture. Swarming is defined as 
rapid translocation across a semisolid surface [48], and Tremblay and Deziel suggested that 
swarming behavior is not virulent, but rather, is a method by which a colony quickly controls a 
maximum amount of space [103]. 
 
II. e. Siderophores   
In order to thrive in any environment, all living organisms must find a way to meet iron 
nutrient demands to carry out essential metabolic processes. While most eukaryotes are capable 
of acquiring iron through diet and humans meet most of their iron nutritional demands through 
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the recycling of red blood cells by macrophages, bacteria must possess some kind of iron-uptake 
system to do the same (reviewed in [18]). Upon invasion of a host, bacteria must free iron from 
different sources such as the heme groups found in hemoglobin or lactoferrin present in mucosal 
secretions and neutrophils [18]. Caza and Kronstad outlined four microbial iron uptake systems in 
their review of bacterial and fungal iron acquisition. The first system is the secretion of 
hemolysins to lyse red blood cells and uptake heme to acquire iron [18]. The second is the uptake 
of transferrin and lactoferrin [18]. The third system is the secretion of siderophores, low 
molecular weight chelators capable of binding to environmental iron and taking it into the cell 
where it is broken down and freed from the transporter ferric complex [13]. Finally, the fourth 
iron uptake method is the direct uptake of ferrous iron [18].  
P. aeruginosa secretes two siderophores, pyoverdine and pyochelin, in iron-limiting 
conditions. The presence of two siderophore systems in P. aeruginosa is interesting, considering 
that pyoverdine has a much higher affinity for iron than pyochelin does. However, since 
pyochelin is able to bind to other metal co-factors, this second siderophore most likely plays an 
additional role in metal homeostasis. Brandel, et al. [13] confirmed that while pyochelin is rarely 
synthesized, even in clinical isolates, its primary role is to facilitate iron uptake, especially when 
the primary pyoverdine-based iron uptake system is deficient. Other studies demonstrate that 
pyoverdine and pyochelin are capable of increasing P. aeruginosa’s tolerance to toxic metal ions 
in the environment [13]. This observation lends further support to the siderophores’ probable role 
in metal homeostasis. 
 
II. e. i. Pyoverdine  
One of the major siderophores in P. aeruginosa, pyoverdine (PVD) is also found in other 
fluorescent pseudomonad species (reviewed in [91]). It is characterized by its green-yellow 
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pigment that fluoresces blue under UV light [74]. Structurally, pyoverdine consists of a 
fluorescent chromophore linked to a strain-specific peptide and a side chain bound to the 
chromophore (reviewed in [91]). A single pvd locus in the PAO1 genome contains nearly all the 
genes for synthesis and uptake [54]. Iron uptake occurs when the apo-PVD is secreted outside the 
cell and binds to iron. The ferr-PVD complex then binds to the outer membrane receptor FpvA 
[54]. PAO1 has three types of pyoverdine: PVDI, PVDII, and PVDIII.  
With regard to pulmonary infections, pyoverdine is an important asset to a bacterium 
attempting to colonize an environment with a low availability of free iron. Colonization is further 
hindered by neutrophil-gelatinase-associated lipocalin (NGAL), an innate defense protein that 
targets bacterial siderophores in both apo- and ferric forms [79]. However, pyoverdine evades 
binding to NGAL in both apo- and ferric forms due to its inability to bind to the ligand-pocket of 
NGAL, allowing P. aeruginosa to establish infection within an otherwise hostile environment 
[79]. 
In addition to its traditional role as an iron-sequestering molecule, Lamont et. al showed 
that pyoverdine also acts as a signaling molecule controlling the expression of exotoxin A, PrpL, 
an exoprotease, and pyoverdine itself in P. aeruginosa [61]. Pyoverdine is also thought to have a 
role in biofilm control, cell-to-cell communication, and virulence factor regulation [54].  
 
II. e. ii. Pyochelin 
 Pyochelin (PCH) is the other major siderophore of P. aeruginosa and it is produced 
through the condensation of salicylate and cysteine [24]. It is structurally different from 
pyoverdine, containing two thioazoline and thiozolidine heterocyclic rings [20]. Pyochelin binds 
to iron in a 2:1 ratio [24] but it is also capable of chelating other biologically significant metals 
such as copper(II) and zinc(II), suggesting pyochelin may play a specific role in metal 
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homeostasis [13]. Two gene clusters, pchDCBA and pchEFGHI, are responsible for biosynthesis 
but the specifics of pyochelin expression are regulated by cytoplasmic iron concentrations and the 
binding of chelated iron to cytoplasmic regulator protein PchR [13]. Unlike pyoverdine, 
pyochelin utilizes FptA for outer membrane transport [13] and FptX for inner membrane 
translocation [24].  
 Chelated iron from the environment is transported to the cytoplasm where it activates 
PchR to induce pyochelin synthesis and activate genes necessary for iron uptake[13]. 
Immediately after synthesis in a siderosome, pyochelin is exported outside the cell to avoid 
accidental iron chelation in the cytoplasm [24]. Synthesis is later inhibited when iron(II) in the 
cytoplasm binds to the Fur protein to stop further iron acquisition in order to maintain iron 
homeostasis in the bacterium [13].  
 Unlike pyoverdine, pyochelin is able to fit inside the ligand-binding pocket of NGAL, but 
it does not bind strongly to NGAL [79]. This suggests that while pyochelin may be recognized by 
NGAL, the overall host response to P. aeruginosa siderophore secretion remains mostly absent 
due to the bacterium’s reliance on pyoverdine to act as the major siderophore contributing to 
successful infection and biofilm establishment [79]. 
 
II. f. Pigments 
 The pigments of P. aeruginosa are easy to identify on solid media and serve secondary 
roles in signaling, metabolism and virulence. Pyocyanin presents as a blue-green soluble pigment 
and is discussed below. The role of pyoverdine, a green-yellow, fluorescent pigment, as a 
siderophore was described in depth previously. Pyomelanin is a red-brown pigment and pyorubin 
is red in color [109]. The exact functions of pyomelanin and pyorubin are unknown but some 
researchers believe they play a role in protection from oxidative stress [34]. 
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II.f. i. Pyocyanin 
Among the pigments it produces, P. aeruginosa is most known for the production of 
pyocyanin (PCN), a blue-green pigment. It is a redox-active secondary metabolite, a member of 
the phenazines, and has a low molecular weight. As a zwitterion, it is capable of passing through 
biological membranes. Pyocyanin interferes with several mammalian cell functions such as cell 
respiration, prostacyclin release from lung endothelial cells, and IL-2 release, which limits T-
lymphocyte growth. It is also able to initiate redox cascade in order to inhibit microbial growth, 
enabling P. aeruginosa to dominate in the CF lung [84]. Furthermore, research suggests that 
pyocyanin plays a role in epithelial cell dysfunction, altered pulmonary immunity, and proteolytic 
injury [84].  
Pyocyanin synthesis is regulated by an AHL-quorum sensing system using OdDHL 
autoinducer. Specifically, synthesis is regulated by RhlR, whose transcription is controlled by 
LasR [71]. PCN is made from chorismate, an intermediate in salicylic acid production. It is 
mediated by two phzsABCDEFG operons and by phzH, phzM, and phzS gene products, which 
modify precursors into pyocyanin (reviewed in [62]).  
An in vivo model of acute pulmonary infection caused by P. aeruginosa revealed that 
pyocyanin and other phenazine tox metabolites impede neutrophils through distinct mechanisms, 
most notably the reduction of chemokines and cytokines. The reduced number of neutrophils and 
acceleration of neutrophil apoptosis are linked to impaired bacterial clearance [2]. Mowat, et al. 
demonstrated that there is a direct link between pyocyanin overproduction and pulmonary 
exacerbation, suggesting that pyocyanin is a major contributor to symptoms associated with 
pulmonary exacerbations [72]. Furthermore, changes in the CF lung during exacerbation periods 
may favor the selection of pyocyanin overproducing isolates [72]. 
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II. g. Proteases 
P. aeruginosa produces a number of proteases capable of destroying host tissues. The 
most widely studied are elastase A, elastase B, alkaline protease, and protease IV, however, other 
exoproteases are in the process of being characterized [56]. Skim milk plates are often used to 
identify protease production, as many proteases secreted by P. aeruginosa are capable of 
degrading the milk protein, casein [98]. As classic virulence factors, the identification and study 
of proteases is important to understand P. aeruginosa infection in depth. 
 
II. g. i. Elastase 
Elastase is an enzyme capable of breaking down elastin, a fibrous glycoprotein found in 
connective tissue. P. aeruginosa secretes two kinds of elastase. The first, elastase A, is a 
metalloproteinase 27 kDa in size and also known as LasA or staphylolysin [56].  Elastase A is 
shown to increase the range of substrates degraded by elastase B and destroys host defense 
proteins [15]. The second is elastase B, a metalloproteinase 33 kDa in size and also called LasB 
or pseudolysin [56]. Encoded by the lasB gene, elastase B is thought to damage host tissue by 
hydrolyzing components of the extracellular matrix. Other studies suggest elastase breaches the 
endothelial and epithelial barriers by attacking tight junctions. A study by Kung et al. in 2011 
showed that P. aeruginosa elastase degrades surfactant protein A (SP-A) in mouse lungs, a 
component of the innate immune system that contributes to pulmonary surfactant and reduces 
phagocytosis in the lungs [59]. SP-A also opsonizes microbes and permeabilizes membranes [59]. 
Further experiments by Kuang et al. showed that a ΔlasB mutant is attenuated in SP-A+/+ mice 
lungs and virulent in SP-A-/- mice lungs [59]. Their work also showed that the inability to secrete 
elastase reduces P. aeruginosa’s ability to degrade SP-A and successfully colonize the lungs [59]. 
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II. h. Hydrogen cyanide 
The production of hydrogen cyanide (HCN) has long been identified as a major 
extracellular virulence factor contributing to the high mortality of burn wound patients [8]. It is a 
toxin against many eukaryotes, demonstrated in a Caenorhabditis elegans model [80]. Previous 
research has shown that mucoid P. aeruginosa actively transcribes the hcnA gene that encodes 
HCN synthase, the enzyme responsible for the conversion of glycine to hydrogen cyanide [8]. 
Cyanide (CN- ) is present in the sputum of CF and non-CF patients and subsequent breath 
analysis has also detected HCN gas present [8]. CN- production occurs through the oxidative 
decarboxylation of glycine via HCN synthase. Immediately after synthesis, HCN gas diffuses and 
acts a direct respiratory inhibitor. The gas binds to cytochrome c oxidase and other 
metalloenzymes, resulting in the lethal inhibition of election transfer chains [4, 8, 80]. Production 
is controlled by a variety of factors, including oxygen availability, metabolic regulator 
compounds, transcriptional regulators including AHL quorum sensing regulators, and the 
presence of ANR (anaerobic regulator of arginine deaminase and nitrate reductase) [4, 8, 80]. 
Because it is such a potent toxin, the detection and quantification of CN- levels in the lung are 
under consideration as a potential, non-invasive marker for P. aeruginsoa infection and the 
invention of rapid techniques to detect HCN production levels have been largely successful [4, 8]. 
 
II. i. Exotoxin A 
 One of the primary toxins of P. aeruginosa is exotoxin A, a single-chain polypeptide 
protein synthesis inhibitor with a molecular weight of approximately 66 kDa (reviewed in [81]). 
Exotoxin A shares biochemical properties with both diphtheria and cholera toxins and its mode of 
action is molecularly defined. Exotoxin A is an ADP ribosyl transferase dependent on 
nicotinamide adenine dinucleotide (NAD) to be enzymatically active and transfer an ADP-ribosyl 
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moiety from NAD to elongation factor 2 [76]. In mice, a 2.5 µg/kg dose of purified toxin is 
necessary for lethality [16, 17] and at sublethal doses, exotoxin A causes epithelial cell necrosis 
in rabbits [53]. Most clinical isolates of P. aeruginosa produce exotoxin A and the human 
immune system is capable of producing antibodies in response to toxin exposure [23, 83]. The 
presence of antibodies within the serum is usually indicative of bacteremia survival and their 
absence is correlated with poor survival rates. Unlike the similar toxin-mediated diseases 
diphtheria and cholera, whose etiological agents cause disease by releasing toxins that bind to 
host cells, P. aeruginosa is capable of invading host cells and the release of extracellular products 
like exotoxin A facilitate this invasion [81]. It is suggested that exotoxin A also acts as an 
immunotoxin due to its toxic effect on immune cells such as macrophages [82]. In a mouse study, 
infection of unimmunized mice with exotoxin A-producing strains of P. aeruginosa exhibited 
more bacteremia and tissue invasion than those who were immunized with exotoxin A-specific 
antibodies, suggesting that exotoxin A may play a role in interfering with bacterial clearance 
mechanisms [77]. 
 
III. Summary 
 Cystic fibrosis is a genetic disorder caused by mutations in the CFTR gene affecting 30, 
000 individuals in the United States and treatment of secondary infections and symptoms is of 
high concern. CF individuals have highly viscous mucus secretions that result in poor pathogen 
clearance. The formation of a diverse polymicrobial community in the lower airways leads to 
chronic inflammation and tissue destruction.  
 P. aeruginosa is the dominant pathogen in CF adults and its ability to hypermutate and 
readily adapt to its environment makes it resistant to treatment even with antimicrobial agents. It 
produces a wide variety of virulence factors necessary for invasion and host cell destruction. 
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Virulence factors investigated in this study are siderophores, proteases, proteins for flagellar 
movement and adhesin, and toxins.  An intricate hierarchy of quorum sensing systems mediates 
the regulation of most of these virulence factors and environmental conditions such as oxygen 
and nitrate levels also affect protein activity.  
 The relationship between virulence factor production in P. aeruginosa and the 
advancement of cystic fibrosis has been subject to much scrutiny in adults. This study aims to fill 
gaps in CF research regarding the variances in virulence factor expression in children and 
adolescent patients. Furthermore, this lays the foundation for further studies in the interactions of 
P. aeruginosa virulence factors and other members of the polymicrobial community present in 
the lungs. 
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CHAPTER III 
 
 
METHODOLOGY 
 
 
 
I. Repository 
I.a. Collection  
Sputum samples were collected from patients by the Oklahoma Cystic Fibrosis staff in 50 
mL sterile conicals. The clinic staff provided information on the patient’s age, sex, and medical 
condition upon admittance to the clinic, and a patient identification tag assigned to the sample. 
Approximately 150 µL of sputum was aliquotted into 150 µL of 50% glycerol and frozen on dry 
ice for transport back to Stillwater. Another 150 µL of sputum was saved into a cryovial and also 
frozen on dry ice for transport. If additional sputum remained after streaking on selective media 
and stabilization of two 150 µL aliquots of sputum in DNA/RNA Shield, then the remaining 
sputum was also added to the 50% glycerol and whole sputum stocks before freezing on dry ice 
for transport. Both sputum samples were stored long term at -80°C. 
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I.b. gDNA and RNA Extraction 
Approximately two 150 µL aliquots of sputum were stabilized in DNA/RNA Stabilizer 
(Zymo) and frozen on dry ice for transport. gDNA was extracted using Quick-gDNA Extraction 
Kit (Zymo) and stored at 4°C. RNA was extracted using Quick-RNA Extraction Kit (Zymo) and 
stored at -80° C. In both kits, sterile water was used as the elution buffer instead of the provided 
solution to prevent downstream enzymatic processes. 
 
I. c. Growth on Nutrient and Selective Media  
Using a cotton swab, sputum was struck onto eight different nutrient and selective media: 
Brain Heart Infusion (BHI) agar (Criterion), Miller Luria-Bertani agar (LB) (Fisher), Nutrient 
agar (NA) (Difco), Skim milk protease agar (adapted from Sokol [98]), Mannitol Salts agar 
(MSA) (BBL), Burkholderia cepacia Selection agar (BCSA) (8.0 g peptones, 1.0 g NH4 SO4, 5.0 
g C3H3NaO3, 0.2 g Mg2SO4, 0.01 g (NH4)2Fe(SO4)2, 4.25 g KH2PO4, 1.42 g Na2HPO4, 0.5 g bile 
salts, 15.0 g agar in 1.0 L H2O adjusted to pH 6.4. After autoclaving, solutions were allowed to 
cool, followed by the addition of 1 mL 0.05 g/50 mL 1000X crystal violet, 1 mL 1 g/50 
mL1000X phenol red, 1 mL 2 g/20 mL 1000X ticarcillin and 1 mL 0.75 g/20 mL 1000X 
polymixin B was added to agar solution before pouring plates), MacConkey’s agar (MAC) 
(Difco), and Pseudomonas Isolation agar (PIA) (Criterion). Plates were incubated at 37°C for 72-
96 hours. 
 
I. d. Colony Morphology  
Colony morphology was recorded on all plates with recoverable growth. Other 
biochemical characteristics, such as protease production and mannitol fermentation, were also 
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noted at this time. All plates were photographed using a Canon EOS Rebel SL1 digital single lens 
reflex camera body and a Canon EF-S 18-55mm f/3.5-5.6 IS STM standard zoom lens. 
 
I. e. Freezer Stocks  
Recoverable growth from BHI, LB, NA, Skim Milk, MSA, BCSA, MAC, and PIA was 
harvested from plates and frozen at -80°C in 2 mL of 10% skim milk in a cryovial. Each vial is 
labeled with the patient identification tag, the media growth was collected from, and the date the 
freezer stock was made.  
 
II. Freezer Block 
II. a. Isolation  
Patients were selected on the basis of age and growth on Pseudomonas Isolation agar. A 
child (under 13), two adolescent (13-18), and two adult (over 18) patients with growth on PIA 
were selected to make freezer blocks in order to test the variance in virulence factor expression. 
Using a wooden inoculating stick, the PIA freezer stock was serially struck on PIA to collect 
individual colonies. Plates were incubated at 37°C for 24-48 hours. 
 
II. b. Block  
A 96-well block was filled with 1 mL of BHI broth. 96 colony-forming units were picked 
using a wooden toothpick and inoculated the block. The block was sealed with aluminum sealing 
foil and incubated shaking overnight at 220 RPM and 37°C. To collect the cell pellet, the block 
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was centrifuged for 5 minutes at 4200 RPM at 20°C.  The supernatant was discarded and the cell 
pellet resuspended in 900 µL of 10% skim milk. Patient blocks were stored long-term at -80°C. 
 
II. c. Stamp Plate  
Using a 48-pin replicator, half of the freezer block was stamped onto LB agar to create a 
working stock for phenotypic assays. Plates were incubated at 37°C for 48 hours. Thirty colonies 
were randomly selected from the stamp plate and consistently used throughout all phenotypic 
assays.  
 
III. Controls  
In all assays, Pseudomonas aeruginosa PAO1 was used as a control. For pigment 
production assays, Pseudomonas fluorescens ATCC 13525 was additionally used as a control. 
For motility assays, Pseudomonas aeruginosa pA1092-245 (ΔfilC) [60] and pA4525-33348 
(ΔpilA) [99] were also used. All strains were struck from freezer stocks using a wooden 
inoculating stick and incubated for 24-48 hours at 37°C, with the exception of P. flurorescens 
ATCC 13525 which was incubated at 30°C. PAO1 and ATCC 13525 were grown on LB agar. 
pA1092-0245 and pA4525-33348 were grown on LB agar containing 60 mg/mL tetracycline. 
 
IV. Virulence Factors 
IV. a. Hydrogen Cyanide 
Hydrogen cyanide production was assessed according to Cody et al. [21]. A detection 
solution was made consisting of 40 mg 4,4’-methylenebis, 40 mg Cu(II)ethyl acetoacetate, and 20 
28	  
	  
mL chloroform. A 6mm filter disk was soaked in the detection solution and left to air dry on the 
plate lid. A lawn of each sample was inoculated on a small petri plate of LB agar using a cotton 
swab. Plates were incubated inverted at 37°C for 24 hours. The filter disk was checked for a blue 
color change. 
 
IV. b. Pigment Production 
IV. b. i. Pseudomonas Medium B for Pyoverdine Production  
Pseudomonas Medium B (PMB) was made according to Atlas [6]: 20.0 g peptone, 15.0 g 
agar, 10.0 g glycerol, 1.5 g MgSO4 7 H2O, and 900 mL of distilled water. One hundred mL of a 
K2HPO4 solution (1.5 g K2HPO4 dissolved in 100 mL distilled water) was also autoclaved with 
the media and added after sterilization. Samples were spot struck three per plate and incubated at 
37°C for 24 hours. Color production and fluorescence under UV light was recorded. 
 
IV. b. ii. Pigment Production during Denitrification 
Denitrification media was made according to Atlas [5]: 10.0 g glycerol, 10.0 g KNO3, 
3.0 g yeast extract, 1.5 g (NH4)2SO4, 1.0 g agar, 0.8 g K2HPO4 3 H2O, 0.5 g MgSO4 7 H2O, 0.2 g 
KH2PO4, 0.1 g CaCl2, 1 L distilled water. Samples were stab-inoculated and incubated 37°C. 
Growth was checked at 24 and 48 hours. Color production, fluorescence, and media liquification 
was recorded.  
Media liquification as a positive indicator for denitrification may be explained by the 
stability of agar, which weakens at low pH values. In traditional soil pH experiments, the 
presence and level of nitrogen will increase the acidity of the soil [104]. For the Pseudomonas 
denitrification medium, the potassium nitrate served as a nitrate source and released nitrogen by 
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the denitrification process will lower the pH of the media. This in turn weakens the agar’s ability 
to remain solid and liquifies the media. 
 
IV. c. Siderophore Production 
Chrome Azurol S media was prepared according to Schwyn and Neilands [93]. All 
glassware and utensils were first acid washed. 10 mLs of a Fe(III) solution (27.03 mg FeCl3 6H2 
O, 1 mL 1M HCl, and 99 mL of nanopure H2O) was mixed with a CAS solution (60.5 mg of 
Chrome Azurol S dissolved in 50 mL of nanopure water). The CAS solution was added to a 
CTAB solution (72.9 mg CTAB/HDTMA dissolved in 40 mL nanopure H2O) in a 250 mL bottle. 
In a separate 1L bottle, an agar solution (1 g NH4Cl, 3.218 g Na2HPO4 7H2O, 1.089 g KH2PO4, 
5.0 g NaCl, and 30.24 g PIPES dissolved in 800 mL nanopure H2O) was prepared and the pH 
adjusted to 6.8. The volume was adjusted to 890 mL with nanopure H2O and both solutions were 
autoclaved for 20 minutes. The solutions were allowed to cool and the CAS solution was mixed 
into the agar solution. One mL of filter sterilized 1M MgSO4 and 10 mL of filter sterilized 50% 
glucose was added to the media before aliquotting 15mL of media per plate. Plates were stored in 
foil at 4°C. Samples were spot struck eight per plate and incubated for 48 hours at 37°C. A 
positive recording for siderophore production was considered to be the agar color change from 
blue-green to orange. Growth and medium color change were recorded. 
 
IV. d. Motility 
IV. d. i. Swimming Motility 
Swimming media was prepared according to Murray and Kazmierczak [73]. 0.3% (w/v) 
LB agar was made and left to air dry. Samples were spot inoculated with a toothpick and 
30	  
	  
incubated for 72 hours at room temperature with additional humidity. Growth diameter was 
measured in centimeters. 
 
IV. d. ii. Swarming Motility 
Swarming media was prepared according to Murray and Kazmierczak [73]. Two g 
glucose, 5 g agar, 0.5 g glutamate, 0.24 g MgSO4, 1 L distilled water. After autoclaving, 100 mL 
of 10x M8 salts (12.8 g Na2HPO4 7H2O, 7.2 g KH2PO4, 2.5 g NaCl, 500 mL H2O) was added. 
Samples were spot inoculated with a toothpick and incubated for 48 hours at 37°C. Growth 
diameter was measured in centimeters. 
 
IV. d. iii. Twitching Motility  
Twitch media was prepared according to Darzins [26]. One % (w/v) LB agar was made 
and left to air dry. Samples were stab inoculated with a toothpick and incubated for 48 hours in 
37°C. The agar was discarded and the plate bottom was left to air dry for two minutes. The twitch 
pattern was visualized with a Coommassie blue stain made of 0.3g Coomassie Brilliant Blue 
dissolved in 45 mL of methanol mixed with 10 mL of Glacial Acetic Acid mixed with 45 mL of 
H2O for a minute and rinsed three times with distilled water. Pattern diameter was measured in 
centimeters. 
 
IV. e. Biosurfactant Production  
Biosurfactant production was assessed using the drop-collapsing test from Lindum et al. 
[64]. An overnight culture was grown in 5 mL of BHI broth and mixed. One mL was aliquotted 
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into a sterile tube and spun down 4200 RPM for 5 minutes. Ten µL of the supernatant was spotted 
in triplicate on a petri dish lid and allowed to incubate at room temperature for 10 minutes. The 
spreading diameter was measured in millimeters. 
 
IV. f. Proteases 
IV. f. i. Caesin Protease Production 
A quantitative skim milk protease media was prepared according to Sokol et al. [98]. 
Using a dialysis tube, 9.25 g BHI was dialyzed in 25 mL of H2O overnight at 4°C. The dialyzed 
BHI solution was mixed with 15.0 g agar, and 450 mL H2O in a 1 L bottle and autoclaved for 30 
minutes with a stir bar. In a separate bottle, 15.0 g skim milk mixed with 500 mL H2O was 
autoclaved for 20 minutes and mixed with the BHI solution. Fifteen mL of media was poured per 
plate. Overnight cultures of each tested isolate were grown in 5 mL of BHI broth. A 1:10 dilution 
was made in BHI broth and the OD600 measured. The sample concentration was determined and 
normalized to an OD600 reading of 0.3. Three µL was spotted in triplicate onto a skim milk plate 
Spots air-dried and the plates were incubated for 24 hours at 37°C. The radius was measured from 
the center of the colony to the edge of the clearing in millimeters.   
 
IV. f. ii. Elastase Production 
The production of elastase was detected using media described by Rust et al. [88]. 
Reverse elastin media was prepared as a 5 mL overlay (0.4 g Nutrient Broth, 1.0 g agar, 0.25 g 
elastin, 50 mL H2O) on nutrient agar (15.0 mL Nutrient Agar/plate). The overlay solution was 
autoclaved for 20 minutes and poured into individual petri plates using a serological pipette. 
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Samples were spot struck eight per plate and incubated for 48 hours at 37°C. Growth and clearing 
of the media was recorded. 
 
IV.g. Cluster Analysis 
 
 Clustering of the results was done in Gene Cluster 3.0 program for Macintosh and viewed 
in Java Tree View. The data included the percent of positive results or average diameter 
measured. Data adjustments were made with the following parameters: mean center genes, and 
mean center arrays. In the hierarchical settings, the genes and arrays were clustered in hierarchy 
using average linkage clustering method.
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CHAPTER IV 
 
 
FINDINGS 
 
 
 
I. Introduction to Repository Collection 
 
 One of the main objectives of the Lutter lab was to build and maintain a repository of CF 
sputa and isolates that can be accessed not only by the Department of Microbiology and 
Molecular Genetics, but also by other departments within and outside Oklahoma State University. 
The Cystic Fibrosis Foundation does have its own library of isolated strains but they impose 
stringent regulations regarding the use of these strains in research. Therefore, it became a high 
priority for this project to build an accessible research repository for future use in our laboratory 
and Department. 
 Collaboration with Dr. James Royall, C.R. Anthony Professor and Chief of Pediatric 
Pulmonology, at the Oklahoma Cystic Fibrosis Center in Oklahoma City was established for the 
purpose of building such a repository. The sputum was collected by the nursing staff and brought 
to a separate room where two aliquots were taken and frozen on dry ice for preservation during
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transport back to Stillwater. The sputum was then struck on eight different types of nutritional 
and selective media in order to collect as much diverse microbial populations as possible. 
Provided there was enough sputum left after plating, two aliquots were stabilized in Zymo 
DNA/RNA Shield and gDNA and RNA were extracted upon return to the laboratory.  
 This specific protocol was established to meet the demands of different research aims. 
Researchers in need of whole sputum to study its composition and effects on microbial 
populations have access to whole sputum, both as is and in 50% glycerol, in this repository. 
Those who study polymicrobial communities and need gDNA or RNA for sequencing have a 
diverse group of patients in all age categories to select from. These represent a few examples for 
which the creation and catalogue of a vast repository of isolates is beneficial to further CF 
research. 
 
II. Results 
  
It is unsurprising that most collected samples come from adult patients as seen in Table 1. 
There is a lack of children and adolescents whose parents or legal guardians consent to study 
participation. As such, the overrepresentation of adult samples in this study is unavoidable. 
Additionally, as the predominant pathogens in children are S. aureus and H. influenzae, the 
number of children infected with P. aeruginosa is few. Children also do not produce much 
sputum and throat swab cultures are easier to obtain from younger patients. This, however, 
prevents an accurate representation of the lower airways’ polymicrobial community from being 
depicted. In an attempt to correlate plate growth with clinical status, there was no evidence that 
clinical status affects the bacterial population present in the lungs, as demonstrated by 
inconsistent recovery of microorganisms on selective media. 
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Table 1: Patient list 
Patient ID Tag Age Condition Sex 
21314a 12 Exacerbation Male 
21314b 10 No exacerbation Female 
21314c 11 No exacerbation Male 
22014a 16 No exacerbation - 
22014b 39 No exacerbation Male 
22014c 23 Exacerbation - 
22014d 29 Exacerbation - 
22714a 55 No exacerbation Male 
22714b 27 Exacerbation Female 
22714c 12 No exacerbation Male 
22714d 31 No exacerbation Male 
22714e 26 Exacerbation - 
3614a 28 No exacerbation Female 
3614b 29 No exacerbation Male 
3614c 38 No exacerbation Male 
31314a 28 No exacerbation Male 
32014a 16 No exacerbation Male 
32014b 41 No exacerbation Male 
5814a* 6 No exacerbation Female 
5814b* 14 No exacerbation Male 
5814c* 5 No exacerbation Male 
5814d* 8 No exacerbation Female 
5814e 11 No exacerbation Male 
5814f* 32 Exacerbation Male 
5814g 20 No exacerbation Female 
5814h 32 Exacerbation Female 
51514a 28 No exacerbation Male 
51514b* 7 No Exacerbation Female 
51514c 16 Exacerbation  Female 
51514d 20 Exacerbation Female 
6514a 19 Exacerbation Female 
6514b 28 No exacerbation Female 
6514c 55 Exacerbation Male 
6514d 20 No exacerbation Male 
6514e* 18 No exacerbation Female 
61214a 24 Exacerbation Female 
61214b 28 No exacerbation  Male 
61214c 22 Exacerbation Male 
61214d 28 No exacerbation Male 
73114a 25 No exacerbation Male 
8714a 13 Exacerbation Male 
8714b* 10 No exacerbation Female 
8714c 32 No exacerbation Female 
8714d* 29 No exacerbation Male 
8714e 26 No exacerbation Female 
81414a* 10 No exacerbation Female 
81414b* 25 No exacerbation Female 
81414c 39 No exacerbation Male 
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81414d 32 - Female 
9414a* 20 No exacerbation Male 
9414b 28 No exacerbation Female 
9414c 33 Exacerbation Female 
9414d 25 Exacerbation Male 
102314a* 7 No exacerbation Female 
102314b* 8 No exacerbation Female 
102314c* 14 No exacerbation Male 
102314d* 8 No exacerbation Male 
102314e* 16 No exacerbation Male 
102314f* 17 No exacerbation Female 
102314g 14 No exacerbation Male 
102314h* 28 No exacerbation Female 
102314i* 25 No exacerbation Female 
102314j* 12 No exacerbation Male 
102314k* 13 No exacerbation Male 
102314l* 18 No exacerbation Male 
102314m* 28 No exacerbation Female 
102314n* 36 No exacerbation Female 
102314o ~30/36 No exacerbation Male 
11614a* 7 No exacerbation Female 
11614b* 12 No exacerbation Male 
11614c* 20 Exacerbation Female 
11614d 10 No exacerbation Female 
11614e 16 Exacerbation Male 
112014a 13 No exacerbation Male 
112014b 24 No exacerbation Male 
112014c 32 Exacerbation Male 
112014d 26 Exacerbation Male 
112014e 10 No exacerbation Female 
2515a 39 Exacerbation Male 
2515b 30 Exacerbation Male 
2515c 30 Exacerbation Male 
2515d 17 No exacerbation Male 
21215a 13 Exacerbation Male 
21915a 33 Exacerbation Male 
21915b 40 No exacerbation Male 
* denotes a throat swab was collected instead of sputum 
- indicates information was not provided 
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A total of 85 samples were collected from the Oklahoma Cystic Fibrosis Clinic at the University 
of Oklahoma Children’s Hospital from February 2014 to February 2015 and are listed in Table 1. 
Of these, 28 were throat swabs and the remaining 57 are sputum samples. From the sputum 
samples, 7 were collected from children, 9 from adolescents, and 41 from adults. Among those 
samples, 1 child, 4 adolescents, and 19 adults were experiencing pulmonary exacerbations or 
receiving treatment for respiratory distress at the time of sampling. 
As stated previously, one of the purposes in building a repository that includes sputum, 
gDNA, and RNA is to foster collaborations within and outside Oklahoma State University. Table 
2 is a comprehensive list of those patients who have available sputum, in both 50% glycerol and 
without any additives, gDNA, or RNA for studies. Of the 85 collected samples, 52 patients have 
associated glycerol sputum stocks and whole sputum frozen at -80 °C. 43 patients have gDNA 
and RNA extracted from the sputum.  
 Each patient had sputum struck onto three nutrient media (BHI, LB, NA) and four types 
of selective media (MSA, BCSA, MAC, PIA). After incubation of all nutritional and selective 
media plates at 37°C, the plates demonstrating microbial growth were noted for colony 
morphology and photographed for record-keeping purposes. A plus mark in Table 2 indicates that 
the sputum cultured microorganisms on that particular media type. This growth was termed as 
“recoverable growth” and will be referred to as such throughout the course of this text. 
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Table 2: Patients with Sputum, gDNA, and RNA 
Patient ID Tag Sputum in 
50% Glycerol 
Sputum gDNA RNA 
21314a + + + + 
21314b + +   
21314c + +   
22014a + + + + 
22014b + + + + 
22014c + + + + 
22014d + + + + 
22714a     
22714b + +   
22714c   + + 
22714d + + + + 
22714e + +   
3614a + + + + 
3614b + + + + 
3614c + +   
31314a + + + + 
32014a     
32014b + + + + 
5814a*     
5814b*     
5814c*     
5814d*     
5814e + +   
5814f*     
5814g + +   
5814h     
51514a + + + + 
51514b*     
51514c + + + + 
51514d + + + + 
6514a + + + + 
6514b + + + + 
6514c + + + + 
6514d + + + + 
6514e*     
61214a + + + + 
61214b + + + + 
61214c + + + + 
61214d + + + + 
73114a + + + + 
8714a + + + + 
8714b*     
8714c + + + + 
8714d* + +   
8714e + + + + 
81414a*     
81414b*     
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81414c + +   
81414d + + + + 
9414a*     
9414b + + + + 
9414c + +   
9414d + +   
102314a*     
102314b*     
102314c*     
102314d*     
102314e*     
102314f*     
102314g + + + + 
102314h*     
102314i*     
102314j*     
102314k*     
102314l*     
102314m*     
102314n*     
102314o + + + + 
11614a*     
11614b*     
11614c*     
11614d   + + 
11614e + + + + 
112014a + + + + 
112014b + + + + 
112014c + + + + 
112014d + + + + 
112014e + + + + 
2515a + + + + 
2515b + + + + 
2515c + + + + 
2515d + + + + 
21215a + + + + 
21915a     
21915b + + + + 
+ indicates the patient has sputum, gDNA, or RNA available for research 
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Table 3: Growth on Selective Media 
Patient BHI LB NA S. Milk MSA BCSA MAC PIA 
Under 13         
21314a + +  +   +  
21314b + +  +   +  
21314c +        
22714c + + + + + + + + 
5814e + + + + +     
11614d + + + + +    
112014e + +       
         
13-18         
22014a + + + + +  + + 
32014a + + + + + + + + 
51514c + + + + + +   
8714a + + + + +  + + 
102314g + + + +     
11614e + + + + +  + + 
112014a + + + + + + +  
2515d + + + + + + + + 
21215a + + + + + + + + 
         
Over 18         
22014b + + + + +  + + 
22014c + + + + + + + + 
22014d + + + + +  + + 
22714a + + + +   + + 
22714b + + + + + + + + 
22714d + + + + +  + + 
22714e + + + + +  + + 
3614a + + + + + + + + 
3614b + + + + + + + + 
3614c + + + + +  +  
31314a + + + + +  + + 
32014b + + + + + + + + 
5814g + + + + + + + + 
5814h + + + + +    
51514a + + + + +    
51514d + + + + + + + + 
6514a + + + + +    
6514b + + + +  + + + 
6514c + + + + + + + + 
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6514d + + + + + + + + 
61214a + + + + +  + + 
61214b + + + + +    
61214c + + + + + + + + 
61214d + + + + + + + + 
73114a + + + + +  + + 
8714c + + + + + + +  
8714e + + + + +  +  
81414c + + + + +  + + 
81414d + + + + + + + + 
9414b + + + + + + + + 
9414c + + + + +  + + 
9414d + + + +   + + 
102314o + + + + +  + + 
112014b + + + + + + + + 
112014c + + + + + + + + 
112014d + + + + +  + + 
2515a + + + +   + + 
2515b + + + + +  + + 
2515c + + + + +  + + 
21915a + + + + + + + + 
21915b + + + + +    
+ denotes the sputum cultured microorganisms on media 
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As seen in Table 3, patients are colonized with a diverse population of microorganisms. In 
addition to Pseudomonas, the salt-tolerant organisms that have also been isolated are most likely 
to belong to the Staphylococcus genus. Fungi have also grown on both nutrient and selective 
media in a select number of patients. Individuals isolates observed on BCSA have had their 16S 
gene sequenced by an undergraduate student and matched to Achromobacter spp., Acidovorax 
spp., and Stentrophomonas maltophilia sequences.  
 
II. a. Clinical Status of CF patients 
 After observing recovered growth, we asked the question if growth recovered from 
selective media correlates with the clinical status of the patient. Table 4 is the same as Table 3 
with an added field for clinical status. An “e” denotes that the patient was experiencing an 
exacerbation at the time of sputum collection. 
The relationship between clinical status and recoverable growth on media does not appear 
to have any correlation with each other. There are inconsistencies in recoverable growth between 
patients experiencing exacerbations. As an example, Patient 61214c has recoverable growth on all 
nutrient and selective media but Patient 61214b does not have recoverable growth on BCSA, 
MAC, and PIA, yet both patients were experiencing exacerbations. This indicates that pulmonary 
exacerbation may not be dependent on the composition of the polymicrobial community, a 
finding that agrees with current literature [37]. 
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Table 4: Clinical Status and Growth on Selective Media 
Patient Exacerbation BHI LB NA S. 
Milk 
MSA BCSA MAC PIA 
Under 13          
21314b  + +  +   +  
21314c  +        
22714c  + + + + + + + + 
5814e  + + + + +     
11614d  + + + + +    
112014e  + +       
21314a e + +  +   +  
          
13-18          
22014a  + + + + +  + + 
32014a  + + + + + + + + 
102314g  + + + +     
112014a  + + + + + + +  
2515d  + + + + + + + + 
51514c e + + + + + +   
8714a e + + + + +  + + 
11614e e + + + + +  + + 
21215a e + + + + + + + + 
          
Over 18          
22014b  + + + + +  + + 
22714a  + + + +   + + 
22714d  + + + + +  + + 
3614a  + + + + + + + + 
3614b  + + + + + + + + 
3614c  + + + + +  +  
31314a  + + + + +  + + 
32014b  + + + + + + + + 
5814g  + + + + + + + + 
51514a  + + + + +    
6514b  + + + +  + + + 
6514d  + + + + + + + + 
61214d  + + + + + + + + 
73114a  + + + + +  + + 
8714c  + + + + + + +  
8714e  + + + + +  +  
81414c  + + + + +  + + 
81414d  + + + + + + + + 
9414b  + + + + + + + + 
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9414c  + + + + +  + + 
102314o  + + + + +  + + 
21915b  + + + + +    
22014c e + + + + + + + + 
22014d e + + + + +  + + 
22714b e + + + + + + + + 
22714e e + + + + +  + + 
5814h e + + + + +    
51514d e + + + + + + + + 
6514a e + + + + +    
6514c e + + + + + + + + 
61214a e + + + + +  + + 
61214b e + + + + +    
61214c e + + + + + + + + 
9414d e + + + +   + + 
112014c e + + + + + + + + 
112014d e + + + + +  + + 
2515a e + + + +   + + 
2515b e + + + + +  + + 
2515c e + + + + +  + + 
21915a e + + + + + + + + 
e indicates the patient experienced pulmonary exacerbation at time of sample collection 
+ denotes the sputum cultured microorganisms on the media 
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II. b. Inter-patient Colony Morphology Variability 
A wide diversity of microorganisms has been isolated from sputa. The recoverable 
isolates show a wide range of colony morphologies, such as smooth and rough phenotypes, and 
biochemical characteristics that are either representative of different species or phenotypes of the 
same species. Most plates grow heavily mixed cultures after incubation and Figure 1 represents 
the vast diversity of the CF lung. Even in nutrient media like BHI and LB, the high degree of 
observed diversity between patients is remarkable because no two patients will cultivate growth 
on nutrient media with identical colony morphologies and the same amount of growth of each 
observed morphology. Figure 1 represents a sampling of the colony morphologies of the 
recovered microorganisms.  
With special attention to the growth on selective media, a wide array of colony 
morphologies and biochemical characteristics have been observed. Both protease producers and 
non-protease producers have grown on skim milk agar and fungi typically grow the best on this 
media. Mannitol Salts agar (MSA), which is traditionally used for the isolation of Gram-positive, 
salt-tolerant organisms and the identification of Staphylococcus aureus by mannitol fermentation, 
shows both white and yellow colonies in large and pinpoint sizes in Fig, 1E. Colonies on 
Burkholderia cepacia Selection agar (BCSA) tend to be very small and purple in color, as seen in 
Fig. 1F, with occasional pink discoloration of the agar demonstrated in Fig. 2F. Colony growth 
observed on MacConkey’s agar represents a potential niche for further study. These 
MacConkey’s isolates are usually smaller in size and purple in color.  
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Figure 1: A representation of the diversity of microbial growth seen on nutrient and selective 
media. A was growth on BHI that shows a mixed culture of smooth and rough colony types with 
some green pigment production seeping into the agar. B showed a mixture of flat and rough 
colonies with no agar discoloration. C was growth on NA showing translucent and light brown-
pigmented colonies. D demonstrated growth of a variety of microorganisms and the production of 
casein proteases by a single colony. E was growth on MSA with small, white round colonies co-
cultured with yellow, round colonies that ferment mannitol. F was growth on BCSA with 
pinpoint, purple colonies. G was mixed growth on MAC with pinpoint and large round colonies. 
H was heavily mucoid growth on PIA with a mixture of green and purple agar discoloration and 
pigment production. 
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II.c.  Intra-patient Colony Morphology Variability 
It is of interest to note that comparison of growth on all plate media from a single patient 
exhibits slight differences in recovered growth and morphology. As an example, Patient 32014b 
was chosen because all eight nutrient and selective media yielded recoverable growth. Focusing 
on the growth seen in Fig. 2A, Fig. 2B, and Fig. 2C, they appear to exhibit similar growth of a 
small, cream-colored, smooth colony, but how well they grow and the intensity of pigmentation 
varies from BHI, LB, to NA. This may be explained by the composition of the media themselves, 
as BHI is richer in nutrients than LB, and LB is richer than NA. Additionally, Fig. 2A and 2B 
appear to be single colony cultures but this is contradicted by the mixed culture observed on NA 
(Fig. 2C) and skim milk (Fig. 2D) plates. This apparent contradiction can also be explained by 
differences in nutrient richness. The available nutrients in BHI and LB that are absent in NA may 
encourage the growth of one microorganism over the other. This cream-colored smooth colony 
observed in all three plates may also be growing on top of the flat, translucent colonies seen in 
NA, therefore leading to the observation of a single colony type on BHI and LB. 
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Figure 2: Growth on Selective Media from Patient 32014b. A appeared to be a single culture on 
BHI with smooth, dark cream colonies. B also appeared to be a single culture on LB with smooth, 
light cream-pigmented colonies. C was a mixed culture with smooth, cream-pigmented colonies 
and flat, translucent colonies. D was also mixed culture that cleared the entire plate and had green 
discoloration of the agar, containing flat, translucent colonies, brown, small growth, moist, green 
colonies, and shiny, yellow colonies. E contained light yellow, pinpoint colonies that turned the 
MSA plate yellow. F had pink colonies in large and small sizes with slight pinking of the agar in 
the initial streak. G showed mixed growth of large, yellow green, moist colonies, white, round 
shiny colonies, and translucent, round colonies that also tinted the agar green. Finally, H 
demonstrated growth of indistinguishable mucoid colonies that are blue, green, and cream-
colored and heavy alginate producers.  
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II. d. Fungal Diversity 
Filamentous fungi such as Aspergillus fumigatus and Aspergillus flavus have been 
previously identified in sputum cultures by pyrosequencing [28] and traditional plate culturing 
but their role in respiratory infections is unknown and controversial [47, 52]. Figure 3 
demonstrates the diversity of recovered fungi on various plate media. Most fungal growth is 
either black or white in color and grows into the agar. Fungi isolates grow in filamentous patterns, 
suggesting the fungi cultured on plate media may be A. fumigatus or A. flavus. 
 
II. e. Pseudomonas diversity 
Finally, the growth on Pseudomonas Isolation agar (PIA) may be the most interesting of 
the recoverable diversity. As seen in Figure 4, some adult patients have distinct, cream-colored 
colonies with varying pigment production. Other adult patients produce such mucoid colonies 
that the alginate spills onto the plate lid during incubation. There is usually a bright array of 
colors from blue-green to purple observed. 
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Figure 3: Representation of Fungal Growth Seen on Selective Media. 3A demonstrates a white, 
filamentous growth. 3B shows black, filamentous growth. 3C is an example of a black, slightly 
filamentous fungus. 3D shows two types of fungi on MSA, a light gray filamentous growth and a 
black, filamentous fungus. 3E shows black, non-filamentous fungal growth. 3F demonstrates 
black, highly filamentous fungus growth in co-culture with Pseudomonas. 
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Figure 4: A representation of the diversity of Pseudomonas growth on PIA. A showed heavy 
mucoidy with green and yellow pigment production. B showed individual colonies with yellow 
pigmentation. C was also mucoid growth with green and purple pigment production. D 
demonstrated individual smooth colonies with blue-green pigmentation. E also demonstrated 
individual colonies with yellow pigmentation. F has a mixture of mucoid and smooth colony 
phenotypes with blue-green or yellow pigment production respectively. 
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III. Summary of Repository Collection 
 The collected repository to date represents a collection of sputum, polymicrobial 
communities, and strains from patients of all ages. This library was built to meet the needs of 
various research groups. Whole sputum, recoverable growth, and isolation of gDNA and RNA 
were catalogued within this large repository. 
 With special attention given to the recovered growth seen on selective media, there exists 
a wide diversity of recovered microorganisms on the plates. Although the precise make up of 
these recovered isolates are in need of sequencing to confirm their identities, their roles in 
advancing pulmonary decline and interspecies interactions are niches for potential studies. 
 
IV. Introduction to the Virulence Factors of P. aeruginosa 
 The virulence factors of P. aeruginosa are well-studied and characterized for their role in 
pathogenesis. In CF, the expression of these virulence factors is instrumental for chronic infection 
and advancement in host pulmonary decline. In addition to possessing a dangerous set of 
virulence factors contributing to decreased lung function, the intrinsic antimicrobial resistance 
mechanisms of P. aeruginosa allow the bacterium to avoid clearance by antimicrobial means. 
The inability of the mucocilliary escalator to clear pathogens entrapped by mucosal secretions 
and the formation of polymicrobial biofilms allow for continued persistence of P. aeruginosa in 
the lungs.   
In this study, ten virulence factors were assessed for differences in expression in relation 
to patient age. These factors were chosen on the basis of their contribution to pathogen 
colonization and host tissue destruction. Swim, swarm, and twitch motilities were assessed for 
their role in colonization of the lung. Similarly, the production of biosurfactants to lower surface 
tension allows for P. aeruginosa to establish and maintain proper biofilm architectures. After 
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colonizing the lung, secreted factors that assist in cell-to-cell communication and facilitate 
microbial growth are necessary to remain present in an otherwise hostile environment. These 
secreted factors include the production of quorum sensing signals and siderophores for iron 
uptake, however, this study assessed the production of siderophores only. Similarly, as the 
amount of oxygen present in the lung is highly variable, the use of nitrate or nitrite as an alternate 
electron acceptor is necessary for growth and advantageous for microorganisms residing deep 
within a biofilm that are more limited to oxygen. Finally, the secretion of exoproteins causing 
host damage is key in pathogenesis. The production of proteases, elastases, and the redox 
inhibitor hydrogen cyanide gas were also studied for differences in their expression in varying 
patient age groups. As such, this survey of a selection of virulence factors known to contribute to 
lung colonization and decline of pulmonary function provides the foundation for further studies in 
P. aeruginosa phenotypic expression in different age categories in the context of mixed infections 
and polymicrobial community interactions.   
 
V. Results 
V. a. Hydrogen Cyanide 
The production of HCN is linked to lethal inhibition of cellular respiration as HCN gas 
binds to cytochrome c oxidase and other metalloenzymes to prevent electron transfer from 
occurring [4, 8, 80]. This leads to tissue death and results in pulmonary decline from loss of 
tissue. This study demonstrates that HCN is detected in all patients; however, the amount varies 
from patient to patient. Figure 5 suggests that HCN production peaks in the early stages of 
colonization as indicated by the increase in detected gas from child isolates compared to 
adolescent isolates. In particular, 32014a shows the highest percentage of gas production with all 
isolates testing positive (n=30).  Additionally, the results suggest that after establishment in the 
lung, HCN production wanes, indicated by the decrease in the number of isolates testing positive 
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for gas production from adolescent isolates to adult isolates. That is not to say gas production 
ceases entirely—the amount of weak HCN gas-producing isolates, as indicated by partial blue 
coloration of the filter disk soaked in detection solution, increases from adolescent to adult 
isolates. It is of interest to note that 61214c exhibits the highest amount of non-HCN gas 
producing isolates (20%) and weak gas-producing isolates (63%) since the patient was 
experiencing pulmonary exacerbation at the time of sputum collection. 
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Figure 5: Hydrogen Cyanide Production: All isolates grew on LB plates. PAO1 was positive for 
HCN production. Sample size for patients was n = 30. 22714c was 60% positive, 37% weakly 
positive and 3% negative. 22014a was 73% positive and 27% weakly positive. 32014a was 100% 
positive. 31314a was 87% positive and 13% weakly positive. 61214c was 17% positive, 63% 
weakly positive and 20% negative. 
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V. b. Pigment Production 
While the brightly colored pigments are characteristic of P. aeruginosa, the colored 
molecules also act as important virulence factors. Pyocyanin and pyoverdine are widely studied 
for their role as a secondary redox metabolite and a major siderophore respectively.  In this study, 
pyoverdine production is assessed using Pseudomonas Medium B as described by Atlas. Most 
patient isolates were able to grow on PMB as indicated by the percentage of growth in Figure 6. 
A positive result was indicated by the presence of a green-yellow pigment, which is characteristic 
of pyoverdine. Other possible pigment colors that may be observed are blue-green for pyocyanin, 
red for pyorubin, and red-brown for pyomelanin [109]. Because pyoverdine is fluorescent, plates 
were also observed under UV light to confirm the production of a blue-green fluorescent pigment.  
In general, isolates from all patient ages produce pigments but the amount of pigment 
appears to decline with age, as seen in Figure 6.  Comparison between adult isolates from 31314a 
and 61214c shows a drastic difference in pigment production. This raises the question of whether 
the host’s clinical status affects the phenotypic expression of the colonized P. aeruginosa, as 
31314a was clinically stable and 61214c was experiencing pulmonary exacerbation.  
The final pigmentation assay addressed the question of pigment production during 
denitrification. In conditions of low oxygen or oxygen depravation, P. aeruginosa is able to 
substitute nitrate or nitrite as an electron acceptor [19, 102]. In the CF lung where higher amounts 
of nitrate or nitrite are present and the oxygen demand of the many microorganisms colonizing 
the lung reduces the amount of oxygen available, this ability is extremely important for successful 
chronic infection. Additionally, bacterium located deep within a mucus plug or biofilm matrix 
and not near the surface of a biofilm receives lower amounts of oxygen than those at the surface 
of the biofilm, necessitating the need for an alternate electron acceptor. In an environment where 
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the levels of oxygen, nitrate, and nitrite constantly fluctuate, denitrification plays an important 
role in pathogen survival.  
Most patient isolates grow in the denitrification media and are capable of producing 
green-yellow pigments. Denitrification was assessed by checking the semi-solid media for 
liquification. Preliminary testing showed that PAO1, which is capable of performing 
denitrification, will completely liquify the media after incubation. In contrast, P. fluorescens 
ATCC 13525, which cannot perform denitrification, was able to grow in culture but unable to 
liquify the media.  
It is of interest to note in Figure 7 that the ability to perform denitrification does not 
appear to correlate with pigment production, as many isolates that liquified the media did not 
produce pigments. Adolescent isolates are capable of performing denitrification but between 
22014a and 32014a, the percentages of those producing pigments are different. As previously 
observed in Figure 6, pigment production appears to decline with age. 
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Figure 6: Pseudomonas Medium B for pyoverdine production: PAO1 grew on PMB and was 
100% positive for color production and fluorescence. P. fluorescences  ATCC 13525 also grew 
on PMB and demonstrated color production 13% of the time with 13% of isolates demonstrating 
fluorescence and 20% of isolates demonstrating weak fluorescence. For patients, a sample size of 
n = 30 was used. 100% of 22714c isolates grew on PMB with 100% exhibiting color production 
and 93% of isolates fluoresced while 7% of isolates weakly fluoresced under UV light. 100% of 
22014a isolates grew with 100% of isolates producing color and 93% of isolates fluoresced while 
7% of isolates demonstrated weak fluorescence. 97% of 32014a isolates grew on PMB with 90% 
of growing isolates produced color and 77% of growing isolates demonstrated fluorescence under 
UV light while 17% of growing isolates weakly fluoresced. 100% of 31314a isolates grew with 
57% producing color, and 97% fluoresced under UV light and 3% weakly fluoresced. 100% of 
61214c isolates grew with 13% producing color, and 7% fluoresced while 10% weakly fluoresced 
under UV light.  
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Figure: 7: Pigment production during denitrification: A sample size of n = 30 was used for 
patients.  The uninoculated control demonstrated no growth, pigment production, or liquification. 
PAO1 grew in the media with 100% color production and liquification. P. fluorescens ATCC 
13525 also grew 100% of the time but demonstrated no color production and liquification. All 
22714c isolates grew with 93% producing color, and 53% of isolates completely liquified the 
media, 43% partially liquified the media, and 3% did not liquify the media. All 22014a isolates 
grew, with 100% of isolates producing color and liquifying the media. All 32014a isolates grew 
with 57% producing color and 100% of isolates liquified the media. 97% of 31314a isolates grew 
with 97% of growing isolates producing color, and 67% completely liquified the media, 20% 
partially liquified the media, and 13% did not liquify the media. All 61214c isolates grew with 
3% producing color, and 17% completely liquified the media, 13% partially liquified the media, 
and 70% of isolates did not liquify the media. 
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V. c. Siderophore Production 
The acquisition of iron is necessary for the survival of any bacterium. Unlike eukaryotes 
that are capable of ingesting iron from their food or recycling iron from cellular components to 
use in cellular processes, bacteria must obtain iron through other uptake methods. One iron 
uptake system is the secretion of iron-sequestering molecules called siderophores to scavenge free 
iron from the environment [13]. This is also important in pathogenic infections of host tissues 
where the production of such molecules contributes to successful invasion and colonization of 
host tissues [79]. The two major siderophores of P. aeruginosa, pyoverdine and pyochelin, are 
readily identified using Chrome Azurol S assay [93]. Although the plate does not identify which 
of the siderophores are being secreted, a presumptive identification can be made when the results 
are analyzed alongside PMB growth, which identifies fluorescent pigments of which pyoverdine 
is one.  
As seen in Figure 8, PAO1 readily produces siderophores and is capable of growing on 
an iron-rich media. Most tested isolates also tested positive for siderophore production. 22014a, 
while all 30 tested isolates were capable of growing on the plate, had 3.33% test negative for 
siderophore production. When taken together with the results from Figure 6, the negative isolates 
of 22014a do not appear to produce siderophores at all. Additionally, of the 30 tested isolates of 
61214c, only 83.33% were able to grow on media. From that, 76% of growing isolates tested 
positive for siderophore production and 24% tested negative.  
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Figure 8: Siderophore production: A sample size of n = 30 was used for all patients. PAO1 grew 
100% of the time and was 100% positive for siderophore production. All 22714c isolates grew 
and were all positive for siderophore production. 100% of 22014a isolates grew with 97% 
positive for siderophores and 3% negative for siderophore production. 32014a isolates grew 
100% on media and were 100% positive for siderophore production. 31314a isolates grew 100% 
on media and were 100% positive for siderophore production. 83% of 61214c isolates grew with 
76% of growing isolates positive for siderophore production and 24% of growing isolates were 
negative. 
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V. d. Motility 
Prior studies have emphasized the importance of motility in the colonization of host 
tissues. Patients near the end of their lives show down-regulation of genes associated with 
flagellum synthesis, indicating a lack of need for them in late chronic infection [49]. pA1092-
0245 is a ΔfliC mutant and pA4525-33348 is a ΔpilA mutant. It is expected that pA1092-0245 
will exhibit decreased swim motility and pA4525-33348 will show decreased twitch motility.  
The average colony diameter was measured in swim and swarm motility assays, and the 
average twitch pattern diameter was measured in the twitch motility assay. In comparison to 
PAO1, 32014a isolates exhibit greater motility for twitch (Fig. 11), are comparable for swarm 
(Fig. 10), and lesser motility for swim (Fig. 9).  Isolates from the other adolescent patient, 
22014a, also showed greater twitch motility (Fig. 11) in comparison to other patients, but showed 
lesser swim (Fig. 9) and swarm (Fig. 10) spreading diameters in comparison to 22714c. Isolates 
from child patient 22714c exhibited greater swarm (Fig. 10) and swim (Fig. 9) spreading 
diameters but not twitch (Fig. 11). Isolates from the adult patients, 31314a and 61214c, were 
hardly motile. Taken as a whole, CF isolates exhibit smaller or equal to PAO1 wild-type motility 
diameters. The lone exception is 32014a isolates, which on average have a greater twitch 
diameter than PAO1. This supports the overarching observation that adolescent isolates of P. 
aeruginosa may be actively invading host cells and establishing chronic infections in the 
epithelial cell layer. This supports previous work demonstrating active P. aeruginosa expression 
of virulence factors during the early years of colonization and the increase in the number of loss-
of-function mutants frequently found in adult patients [49, 65, 72, 107], as demonstrated by 
phenotype assays [72, 107], proteome and transcriptome analysis [49], and animal infection 
models [65]. Student’s t-tests were performed on data from isolates taken from children and 
adolescents, adolescents and adults, and adults and children, and all had a p-value < 0.05. 
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Figure 9: Swim Motility: A sample size of n = 30 was used for all patients. PAO1 had an average 
diameter of 38.98 mm (s = 4.87). pA1092-0245 had an average diameter of 35.98 mm (s = 5.72). 
pA 4525-33348 had an average swim diameter of 41.75 mm (s = 5.72). 22714c had an average 
diameter of 33.00 mm (s = 9.58). 22014a had an average diameter of 20.03 mm (s = 4.50). 
32014a had an average diameter of 24.54 mm (s = 7.68). 31314a had an average diameter of 
13.14 mm (s = 4.29). 61214c had an average diameter of 5.47 mm (s = 4.70). Error bars represent 
standard deviation. A single asterisk represents a p-value < 0.05 in comparison to controls. 
Double asterisks represent a p-value > 0.05 in comparison to controls. 
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Figure 10: Swarm Motility: A sample size of n = 30 was used for all patients. PAO1 had an 
average diameter of 17.30 mm (s = 9.80). pA1092-0245 had an average diameter of 14.93 mm (s 
= 6.68). pA 4525-33348 had an average swim diameter of 41.72 mm (s = 18.74). 22714c had an 
average diameter of 8.18 mm (s = 7.11). 22014a had an average diameter of 2.62 mm (s = 2.72). 
32014a had an average diameter of 16.15 mm (s = 10.60). 31314a had an average diameter of 
5.95 mm (s = 2.43). 61214c had an average diameter of 1.42 mm (s = 0.86). Error bars represent 
standard deviation. A single asterisk represents a p-value < 0.05 in comparison to controls. 
Double asterisks represent a p-value > 0.05 in comparison to controls. 
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Figure 11: Twitch Motility: A sample size of n = 30 was used for all patients. PAO1 had an 
average diameter of 18.43 mm (s = 2.75). pA1092-0245 had an average diameter of 8.58 mm (s = 
3.64). pA 4525-33348 had an average swim diameter of 3.83 mm (s = 1.01). 22714c had an 
average diameter of 5.06 mm (s = 1.59). 22014a had an average diameter of 15.11 mm (s = 3.40). 
32014a had an average diameter of 21.64 mm (s = 4.70). 31314a had an average diameter of 
10.83 mm (s = 2.79). 61214c had an average diameter of 5.00 mm (s = 3.36). Error bars represent 
standard deviation. A single asterisk represents a p-value < 0.05 in comparison to controls. 
Double asterisks represent a p-value > 0.05 in comparison to controls. 
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However, the negative motility controls, pA1092-0245 (ΔfliC) and pA4525-33348 
(ΔpilA), did not behave as expected for the swim and swarm motility assays. Subsequent control 
experiments varying in the age of the control strains and in the freshness of the motility media 
consistently produced similar colony diameters for both motility assays. On the other hand, the 
negative controls behaved as expected in the twitch motility assay, with pA4525-33348 (ΔpilA), 
producing the smallest twitch diameter of the three controls. Taken together, this suggests that the 
age of the control cultures and the freshness of the prepared motility media are not contributing 
factors to the explanation of why the negative motility controls were not behaving as expected. 
Further tests are needed to confirm the insertion of the mutation in both control strains prior to 
performing further motility experiments.  
 
V. e. Biosurfactant Production 
The biosurfactant of P. aeruginosa is a class of molecules known as rhamnolipids [27, 
44, 97]. They are essential for proper biofilm formation and play a role in maintaining open 
channels and architecture [27]. The drop-collapsing test qualitatively assesses the production of 
biosurfactant in the supernatant of a liquid culture [64, 111]. The larger the spreading diameter, 
the more biosurfactant is produced.  
In Figure 12, PAO1 had an average spreading diameter of 4.96 mm (s =0.77). Using this 
as a threshold, isolates from children and adolescents produced on average higher amounts of 
biosurfactant, indicated by the larger average spreading diameters. In contrast, adult isolates 
produced lesser amounts of biosurfactant than PAO1, indicated by the smaller average spreading 
diameter. Student’s t-tests were performed on data from isolates taken from children and 
adolescents, adolescents and adults, and adults and children, and all had a p-value < 0.05. This 
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observation lends support to the idea that biofilm establishment early in infection is necessary for 
P. aeruginosa persistence and the development of a chronic infection. 
 
 
 
Figure 12: Biosurfactant Production: A sample size of n = 30 was used for all patients. PAO1 had 
an average spreading diameter of 4.96 mm (s = 0.77). 22714c had an average spreading diameter 
of 6.86 mm (s = 0.79). 22014a had an average spreading diameter of 6.34 mm (s = 0.29). 32014a 
had an average spreading diameter of 5.31 mm (s = 1.20). 31314a had an average spreading 
diameter of 4. (s = 0.13). 61214c had an average spreading diameter of 4. (s = 0.40). Error bars 
represent standard deviation. A single asterisk represents a p-value < 0.05 in comparison to 
control. Double asterisks represent a p-value > 0.05 in comparison to control. 
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V. f. Proteases 
The proteases of P. aeruginosa are classic virulence factors important in pathogenesis for 
host tissue degradation. Several proteases have been thoroughly studied, notably elastase A, 
elastase B, protease IV, and alkaline protease, and their role in infection is well-understood. 
Proteolytic activity is often assessed using casein degradation [86] and this study uses a 
modification of dialyzed BHI with added 10% skim milk [98] to determine protease activity. The 
clearing radius was measured in millimeters from the center of inoculation and the average of all 
isolates for a patient was calculated. Student’s t-tests were performed on data from isolates taken 
from children and adolescents, adolescents and adults, and adults and children, and all had a p-
value < 0.05. 
22714c, the child patient, had an average clearing radius comparable to wild-type PAO1. 
Adolescent isolates also had a comparable clearing radius to PAO1. However, adult isolates had 
noticeable decrease in protease production, with several isolates from 61214c failing to clear the 
agar entirely. Figure 13 suggests that protease production decreases as a chronic infection is 
established. Furthermore, during periods of exacerbation, protease production appears to halt 
completely. 
A similar trend was observed for elastase production. While the reverse elastin media 
does not specifically detect LasA or LasB, it will detect both [88]. Elastase was produced by all 
growing isolates with no correlation to patient age (Fig. 14). However, the amount of positive 
elastase producers drops during exacerbation. This is of interest since elastases are known to 
destroy host proteins [15]. 
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Figure 13: Casein Protease Production: A sample size of n = 30 was used for all patients. PAO1 
had an average clearing radius of 11.40 mm (s = 0.41).  22714c had an average clearing radius of 
11.27 (s = 0.27).  22014a had an average clearing radius of 11.52 mm (s = 0.38). 32014a had an 
average clearing radius of 10.61 mm (s = 0.62). 31314a had an average clearing radius of 9.12 (s 
= 0.71). 61214c had an average clearing radius of 2.47 mm (s = 4.00). Error bars represent 
standard deviation. A single asterisk represents a p-value < 0.05 in comparison to control. Double 
asterisks represent a p-value > 0.05 in comparison to control. 
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Figure 14: Elastase Production: A sample size of n = 30 was used for all patients. PAO1 grew 
100% of the time on elastase media and was 100% positive for elastase production. 100% of 
22714c isolates grew with 100% of isolates positive for elastase production. 100% of isolates 
from 22014a grew on media with 100% positive for elastase production. 100% of 32014a isolates 
grew with 100% positive for elastase production. 90% of isolates from 31314a grew on media 
and 100% of growing isolates produced elastase. 97% of 61214c isolates grew with 17% of 
growing isolates producing elastase and 83% of growing isolates negative for elastase production. 
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V. g. Clustering Analysis 
 The virulence factors of Pseudomonas aeruginosa play pivotal roles in CF infection and 
decline. A total of ten virulence factors were chosen for this survey and thirty isolates from each 
of five selected patients, one from children and two from adolescents and adults, were tested for 
variances in virulence factor expression. On a whole, the chosen set of virulence factors are 
expressed regardless of patient age, however, what does vary is the amount the particular 
phenotype is expressed.  
Several trends can be seen in the data. Hydrogen cyanide production and swimming, 
swarming, and twitching motilities tend to peak at adolescence. Protease and siderophore 
production show a decrease in production as age increases. Pigment production is relatively 
constant with no correlation to patient age. However, a larger sample size taken from more 
patients in each age category will be necessary to determine if these observed trends are truly 
representative of P. aeruginosa host adaptation. In order to best summarize the results of this 
survey, a cluster diagram based on the percentage of isolates testing positive and the average 
diameter was generated (Fig. 15). Patients from the same age category did cluster together, which 
lends support to the idea that phenotypic expression may be related to patient age. It is interesting 
that some factors related to each other did not cluster together. The clustering of biosurfactant and 
protease production was expected since they are extracellular products, however, elastase, a type 
of protease, was not grouped with biosurfactant and proteases. HCN gas production and 
denitrification were grouped together, which was also expected since HCN synthase activity and 
the utilization of denitrification are dependent on oxygen availability. Lastly, pigment production 
did cluster together, as did swim, swarm, and twitch motility.  
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Figure 15: A Cluster Analysis of Results from Phenotypic Assays. Red squares indicate greater 
than average values, black squares represent average values, and green squares are lesser than 
average values.  
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VI. Summary 
 This survey on a selection of P. aeruginosa virulence factors related to pulmonary 
infection supports previous research that comments on the broad phenotypic diversity of P. 
aeruginosa CF isolates [72, 107]. Most isolates taken from CF patients in all age groups express 
the chosen virulence factors and their trends are summarized in Fig. 15. 
 There is one consistent anomaly in all data sets. Patient 61214c is an adult who 
experienced pulmonary exacerbation at the time of sputum collection. In contrast to the rest of the 
patients who are all clinically stable at the time of sampling, 61214c isolates show a surprising 
lack of virulence factor production in all tested areas. This leads to an interesting question: does 
the expression of particular virulence factors and phenotypes not only depend on the surrounding 
polymicrobial community and lung environments, but also on the clinical status of the host? 
Furthermore, what occurs during pulmonary exacerbation that consequently inhibits or down-
regulates the expression of such virulence factors, and does this suppression ensure P. aeruginosa 
persistence?  
Fodor, et. al suggested that exacerbations may represent the spread of infection in the 
lungs or be a consequence of changes in virulence factor expression by the resident polymicrobial 
community [37]. Since P. aeruginosa utilizes three different quorum-sensing systems to regulate 
the production of its many virulence factors, any mutations in the genes transcribing 
autoinducers, receptors, or other involved signaling molecules will result in the expression of 
different phenotypes. It has been established that lasR mutants are associated with growth 
advantages in times of oxidative stress and protection during antibiotic treatment [51]. It has also 
been suggested that lasR mutants may act as social “cheats” using extracellular products, such as 
siderophores, from those isolates in possession of functioning lasR protein [25]. Alternatively, the 
persistence of this particular genotype in the CF lung may be due to it apparent growth advantage 
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in an established infection but there is little evidence to support this hypothesis [46]. Further work 
to address these questions will need to include a larger number of patients in each age category. 
Additionally, the sample size should include both clinically stable and pulmonary distressed 
patients to determine if host clinical status truly does have an impact on virulence factor 
expression. 
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CHAPTER V 
 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 
 
Science has advanced our understanding of CF as a disease at the genetic level and from 
the perspective of its alimentary and respiratory manifestations. It is of great importance that 
further work is done to elucidate as many avenues of possible therapy in order to continue 
improving the livelihood of those afflicted with CF.  
 Antimicrobial treatments have proven to be effective in treating symptoms of pulmonary 
infection but often fail to clear the lungs of microorganisms entirely [37].  This is due to several 
adaptive strategies of the polymicrobial community. First, the transfer of plasmids between 
organisms to confer antimicrobial resistance is not uncommon. Several bacteria, including P. 
aeruginosa and B. cepacia complex, possess beta lactamases and efflux pumps to prevent 
susceptibility to prescribed antibiotics. The high pressure of antibiotics used in the lung also 
selects for those isolates capable of surviving repeated treatment. The emergence of the small-
colony variant phenotype, particularly in S. aureus, is another sub-population that evades 
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chemical therapy and clearance [110]. Third, the formation of polymicrobial biofilms, most likely 
initiated by S. aureus and further developed by P. aeruginosa, allows for many microbial 
populations to remain protected from clearance in the lung. These strategies and many other 
factors contribute to persistence and chronic infection. 
 The creation of a repository of CF isolates accessible to interested research groups opens 
avenues for further exploration into polymicrobial communities. As CF research shifts from focus 
on a single pathogen to a polymicrobial infection, access to clinical samples becomes necessary 
to further work in this field. The broad microbial diversity cultured from the sputum emphasizes 
the unique profiles of the polymicrobial community present within an individual. Therefore, the 
extraction of gDNA and RNA shortly following sputum collection is necessary for 
pyrosequencing and transcriptomic studies. Performing sequencing on gDNA allows us to 
glimpse what organisms, dead and alive, are found in the CF lung [28, 37]. At the same time, 
RNA sequencing gives us information on what organisms are metabolically active [87]. Similar 
studies have been performed by other research groups, but their research was limited to adult 
patients [28, 36, 87]. These two pieces of information together allows us to paint a comprehensive 
view on the composition of the polymicrobial community, including those pathogens that cannot 
be cultured by the methods outlined in Chapter 3 such as anaerobic microorganisms. 
In creating a repository and collecting recoverable aerobic growth, we have cultured a 
large number of microorganisms on nutrient and selective media. No two sputum samples present 
identical colony morphologies on plate media and this suggests there is a broad diversity of 
microorganisms present within the CF patient community. To confirm this assumption, we will 
need to perform sequencing on sputum gDNA to identify the members of the microbial 
community. Additionally, gDNA and RNA have been extracted from a total of 43 samples and a 
preliminary pyrosequencing study has been completed.  
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Because B. cepacia complex infection risks the development of fatal cepacia syndrome, 
the unusual growth observed on BCSA plates was a cause for concern. Subsequent sequencing 
identified these colonies as members of the Acidovorax, Achromobacter, and Stenotrophomonas 
genus. Their growth on BCSA is unexpected, but not unusual, since prior studies demonstrate an 
intrinsic high resistance to multiple antibiotics. More recent microbiome studies have identified 
fungi belonging to the Aspergillus genus and our preliminary sputum cultures lends support to 
their findings. Future studies on fungal growth and infection in the CF lung are possible with the 
isolation of at least three different fungal morphologies from the sputum.  
 Identifying the members of this complex polymicrobial community is the first step in 
understanding what roles they may play in CF infections. Pathogens such as Streptococcus milleri 
group (SMG), Stentrophomonas maltophilia, Achromobacter xylosoxidans, Aspergillus 
fumigatus, and Candida albicans have been identified in the sputum yet their possible role in 
infection is subject to controversy [28, 85]. Streptococcus was identified as the second most 
common bacterial genus in adult CF patients in a recent study by Delhaes and was assumed to be 
species belonging to the SMG [28]. The importance of SMG in CF is its association with 
pulmonary exacerbation and its production of quorum-sensing signals [43]. It is known that A. 
xylosoxidans and S. maltophilia utilize multiple resistance mechanisms including synthesis of Β-
lactamases and efflux pumps, and enzyme modifications to avoid antimicrobial clearance [1]. 
The virulence factors of potential pathogens such as Acidovorax spp. must be identified 
in order to understand what roles they may play in pulmonary infection and overall decline of 
host health. From there, mixed infection studies will elaborate on how the potential pathogen 
interacts with different clones and other CF pathogens such as S. aureus and P. aeruginosa. Insect 
and animal models such as Drosophila [58, 96], murine [9], and porcine [46] models have been 
used in prior studies to understand P. aeruginosa infections and their effect on host health. These 
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same models can be used to understand community interactions and their overall contribution to 
pulmonary decline. 
With the collection of whole sputum samples from a variety of patients in different age 
categories, studies can be performed on the composition of the sputum itself. For example, ion 
concentrations of biologically relevant molecules such as Ca2+ or Fe3+ can be measured by 
separating the pathogens from the extracellular fluid by centrifugation. The extracellular fluid 
contains all extracellular products, including secreted proteases and ions, and the composition of 
the extracellular fluid can be elucidated by mass spectrometry or a similar method.  Similarly, the 
identification of what cytokines and chemokines are present in the sputum will aid in 
understanding the relationship between innate host response and infection.  
 P. aeruginosa is widely recognized as the predominant pathogen in the adult lung and 
interacts with other key species such as S. aureus and B. cepacia complex. The virulence factors 
of P. aeruginosa have been studied and characterized in depth. Current CF research focuses 
heavily on adult isolates, a serious knowledge gap exists for early infections in childhood and 
adolescence. Previous studies demonstrate the vast diversity of P. aeruginosa isolates even within 
a patient. Workentine, et al. noted that within multiple isolates stemming from the same patient, 
there is no consistent expression of a single phenotype across all studied isolates [107]. Mowat, et 
al. attributes this high phenotypic diversity between isolates to rapid turnover of haplotypes due 
to bacterial dynamics within the lung [72]. This necessitates the use of a large sample size to 
create a more accurate representation of P. aeruginosa behavior in the lung. Throughout this 
study, a sample size of n = 30 was used for each surveyed patient and five patients, one from 
children and two from adolescents and adults, were utilized. This study surveys the production of 
ten virulence factors important for pulmonary pathogenesis in three different age groups—
children, adolescents, and adults—in order to better understand shifts in virulence factor 
production in relation to age. These virulence factors are swim, swarm, and twitch motilities, and 
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the production of biosurfactant, proteases, hydrogen cyanide, siderophores, and fluorescent 
pigments during growth and aerobic denitrification. Other research groups have addressed the 
variability of these virulence factors in adult isolates and their research supports our findings [10, 
49, 65, 72, 107], namely that there is a broad phenotypic diversity among isolates from the same 
patient and patients with chronic infections show suppression of virulence factor expression. 
  In summary, the production of virulence factors associated with biofilm attachment and 
maintenance—swim, swarm, and twitch motilities and biosurfactant production—are highest in 
adolescents. This observation may correlate with the increase in the number of patients infected 
with P. aeruginosa in this age category. It reasons that isolates from adolescent patients, which 
may be primed for P. aeruginosa colonization, would have the highest amount of isolates 
expressing swim, swarm, and twitch phenotypes. Similarly, isolates from child patients that 
express motile phenotypes do not have as great of swimming and swarming spreading diameters 
as isolates from adolescents. This may be indicative of the early stages of infection and 
adolescents may be at the peak of P. aeruginosa colonization. It was also observed that isolates 
from adults consistently produce a lower number of isolates testing positive for virulence factor 
production. This agrees with transcriptomic studies that show down-regulation of virulence 
factors at the end stages of life [49]. The sole exception to this observation is the production of 
siderophores, which are necessary for continued survival within the lung.  
 The final relationship observed in this study is the link between expressed virulence 
factors and a patient’s clinical status. Patient 61214c was experiencing pulmonary exacerbation at 
the time of sputum collection and tested isolates from this patient consistently demonstrate a low 
number of isolates expressing the tested phenotype, if not entirely absent. The suppression of 
virulence factors such as protease production during exacerbations may be a mechanism to ensure 
persistence in the lungs, however, the lower percentage of isolates testing positive for siderophore 
production raises a few questions. First, are the non-growers auxotrophic for a substrate present in 
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other media such as LB or PMB that is absent in CAS? What is that substrate and is it present in 
the CF lung? Also, do the siderophore-negative isolates from 61214c represent a previously 
unconsidered phenotype? What advantage does suppression of siderophore production and 
secretion confer on the bacterial fitness, especially during exacerbations? It is known that iron is 
abundant in the sputum as a result of chronic inflammation and that P. aeruginosa down-
regulates siderophore production after the onset of pulmonary infection and the establishment of a 
stable biofilm [79], but determining if this relationship holds true during exacerbations will be 
necessary to validate the suppression of siderophore production in this circumstance.  
 Other factors will need to be considered to explain the differences in virulence factor 
production by isolates from 61214c. For example, does a patient’s age affect the expression of P. 
aeruginosa virulence factors? Similarly, does a patient who has been recently colonized by P. 
aeruginosa show differences in phenotypic expression in comparison to a patient of the same age 
that has been colonized for a longer period of time? Moreover, do shifts in P. aeruginosa isolate 
populations affect clinical status? Fodor, et al. demonstrated that antibiotic treatment during 
exacerbations temporarily improved clinical status but did little in eradicating bacterial 
populations [37]. This leads us to question if the antibiotics used to treat pulmonary exacerbations 
causes shifts in P. aeruginosa virulence factor production. 
 The relationship between exacerbations and P. aeruginosa virulence factor production is 
not well understood. Two hypotheses exist to explain this relationship. The first hypothesis 
suggests that exacerbations, which include an increase in airway inflammation, causes P. 
aeruginosa to produce quorum sensing molecules to initiate the synthesis of virulence factors in 
order to adapt to its new environment. The changes in virulence factor production cause an 
inflammatory response from the destruction of host tissues or the recognition of PAMPs by 
airway epithelial cells. Since the synthesis of the majority of P. aeruginosa virulence factors is 
dependent on environmental signals, such as oxygen concentrations affecting HCN synthase 
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activity [4, 8, 80] and iron availability controlling the production of siderophores, there is strong 
support for this first hypothesis. 
The second hypothesis suggests that virulence factor changes in isolates cause 
exacerbations [37]. This hypothesis postulates that changes in virulence factor expression would 
lead to changes in PAMPs and elicit pro-inflammatory cytokine production by epithelial cells. 
The production of cytokines then leads to increased inflammation and causes exacerbations. Prior 
research demonstrated that overproduction of alginate, a polysaccharide found in P. aeruginosa 
biofilms, initiates the conversion from the smooth to mucoid colony phenotype [42]. This mucoid 
phenotype is associated with a rapid decline in lung function and a hyperimmune response [63, 
78].   
While both hypotheses must be studied in depth, current research appears to favor the 
first hypothesis over the second. Figure 16 graphically represents the first hypothesis as a cycle 
between inflammation and virulence factor production. A previous study showed that P. 
aeruginosa gene products stimulate and increase IL-8 production by epithelial cells [32], which 
leads to an increase in activated NF-κB [31], thereby increasing inflammation in the lungs. 
Because quorum-sensing molecules are produced in response to environmental signals and the 
three quorum-sensing systems control the expression of over 300 genes, it is more likely that 
environmental changes are prompting changes in the phenotypic expression of P. aeruginosa 
isolates. 
82	  
	  
 
Figure 16: Cycle between Inflammation and Virulence Factor Production. Increased airway 
inflammation constitutes part of the clinical symptoms associated with pulmonary exacerbations. 
The increase in inflammation leads to an increase in cytokine production, which then initiates P. 
aeruginosa quorum sensing signal production. Quorum sensing controls the expression of several 
virulence factors and shifts in virulence factor production, such as an increase in pyocyanin, then 
causes tissue damage and leads to further airway inflammation. 
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 Despite the importance of assessing variability in P. aeruginosa phenotypes in children, 
adolescents, and adults, CF is not caused by infection with a singular pathogen. The rapid 
identification of the polymicrobial community is essential for proper diagnosis and the 
prescription of effective treatment [28, 37, 85]. Because these polymicrobial infections are 
present in the CF lung as a biofilm, it is necessary to elucidate virulence factor heterogeneity 
between age groups in a situation that mimics in vivo conditions. The thick mucus in the lungs is 
sufficient for biofilm establishment and this environment can be emulated with artificial sputum 
media (ASM). However, this media has limitations for in vivo work because it is a homogenous 
liquid media that does not reproduce the compositional fluctuations of sputum faithfully [33]. 
Environmental signals like calcium (Ca 2+) have previously been shown to increase P. aeruginosa 
biofilm thickness through the increase in alginate production and is related to higher secretions of 
alkaline protease, elastase B, and PrpL proteases to the extracellular biofilm matrix [90]. Not only 
does the composition of the present polymicrobial community affect P. aeruginosa virulence, but 
also any external factors in the sputum play a role in virulence factor production especially within 
a biofilm.  
 Therefore, in order to determine if the relationships between patient age and the 
expression of the P. aeruginosa virulence factors surveyed in this study, it is necessary to assess 
phenotypic heterogeneity in mixed biofilms and in experimental conditions that mimic the CF 
lung environment. Additionally, a larger sample size for all age groups is necessary to determine 
if the observed trends are representative of the shifts in virulence factor expression and host 
adaptation strategies utilized by P. aeruginosa. Future studies will address these questions in 
depth.
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APPENDICES 
 
 
 
 
 
Appendix I: Representation of Results from Phenotypic Assays 
 
Figure 17: Representation of Hydrogen Cyanide Production Assay. After following inoculation 
and incubation procedures outlined in Chapter 3, a positive result is determined by the blue color 
change of a filter disk soaked in detection solution. The plate on the left is from an isolate used in 
this study and is positive for HCN gas production. The plate on the right is PAO1 and is positive 
for HCN gas production.
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Figure 18: Representation of Pyoverdine Production by PMB. Shown is a single PMB plate 
inoculated with PAO1, P. fluorescens ATCC 13525, a clinical isolate, and an uninoculated 
control section. Both PAO1 and the clinical isolate produce a green-yellow pigment on PMB as 
seen A. PAO1 and the clinical isolate also fluoresce blue-green under UV light as seen in B. On 
the other hand, ATCC 13525 does not produce pigments (A) or fluoresce under UV light (B). 
 
94	  
	  
 
Figure 19: Representation of Pigment Production during Denitrification. A clinical isolate (1D3), 
P. fluorescens ATCC 13525, P. aeruginosa PAO1, and an uninoculated control (blank) have been 
inoculated following the methods outlined in Chapter 3. PAO1 and the clinical isolate both 
produce faint green-yellow pigments and completely liquify the media. ATCC 13525 grows well 
in the media with cream-colored grow but the medium remains solid. The uninoculated control 
shows no grow or pigment production and also remain solid. 
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Figure 20: Representation of the CAS Assay for Siderophore Production. PAO1, P. fluorescens 
ATCC 13525, a clinical isolate (1D3), and an uninoculated control (blank) were struck onto the 
medium. A positive result for siderophore production was assessed with the color change of the 
medium from green-blue to orange. All three inoculated samples turned the medium orange and 
are positive for siderophore production. 
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Figure 21: Representative plates demonstrating the Swim Motility Assay. A shows the swimming 
diameter of PAO1. B is an example of pA1092-0245 swimming diameter. C shows the swimming 
motility of pA4525-33348. Finally, D is an example of the swimming diameter of a clinical 
isolate. In this case, D demonstrates the small swimming diameter frequently observed in clinical 
isolates. 
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Figure 22: Representative plates demonstrating Swarming Motility. A demonstrates the swarming 
pattern of PAO1. B is a swarm motility plate inoculated with pA1092-0245, which shows little 
swarming activity. C shows the swarming motility and tendril pattern of pA4525-33348. Finally, 
D is an example of the swarming diameter of a clinical isolate that does not have a large 
swarming diameter. 
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Figure 23: Representative plates demonstrating Twitch Motility. A shows the twitching diameter 
of PAO1 as stained by Coomassie Blue. B is an example of pA1092-0245, which does not show a 
large twitching diameter. C shows the twitching motility of pA4525-33348, and in this case, it 
does not utilize twitching motility either. Lastly, D shows a dark twitching pattern of a clinical 
isolate and is indicative of some utilization of twitch motility by that isolate. 
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Figure 24: Representative plate demonstrating the Drop-Collapsing Test to Assess Biosurfactant 
Production. The spreading diameter of a drop of supernatant from PAO1 and two clinical isolates 
is measured after incubation at room temperature. In Fig. 23, the supernatant is light yellow in 
color on the petri plate lid. 
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Figure 25: A Representation of Casein Protease Production on D-BHI Skim Milk agar. A shows 
clearing of the agar by PAO1 and two clinical isolates. B also shows clearing of the agar by 
PAO1 but the inoculated clinical isolates on the plates fail to break down casein, indicating a lack 
of protease production. 
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Figure 26: Representative plate demonstrating Reverse Elastin Media to Assess Elastase 
Production. An uninoculated control, PAO1, and two clinical isolates were inoculated on the plate 
and incubated for 48-72 hours. Clearing of the elastin in the media was indicative of elastase 
production. 
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